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1. General introduction
 .Succinate:quinone oxidoreductase EC 1.3.5.1
refers collectively to succinate:quinone reductase
 .SQR, or Complex II and quinol:fumarate reductase
 .QFR . The former enzyme is found in aerobic organ-
isms, and catalyses the oxidation of succinate to
fumarate in the citric acid cycle and donates the
electrons to quinone in the membrane. The latter
enzyme can be found in anaerobic cells respiring
with fumarate as terminal electron acceptor. SQR and
QFR are very similar in composition and seemingly
also in structure in spite of that they catalyze the
opposite enzym atic reac tions in v ivo .
Succinate:quinone oxidoreductases consist of a pe-
ripheral domain, exposed to the cytoplasm in bacteria
and to the matrix in mitochondria, and a membrane-
 .integral domain that spans the membrane Fig. 1 .
The peripheral part, which contains the dicarboxylate
binding site, is composed of a flavoprotein FP;
.64–79 kDa subunit, with one covalently bound FAD,
 .and an iron-sulfur protein IP; 27–31 kDa subunit
w xcontaining three iron-sulfur clusters, a 2Fe-2S clus-
 .  . w xter denoted S1 in SQR or FR1 in QFR , a 4Fe-4S
w xcluster denoted S2 or FR2, and a 3Fe-4S cluster
denoted S3 or FR3. The membrane-integral domain
functions to anchor the FP and IP subunits to the
membrane and is required for quinone reduction and
oxidation. The anchor domain shows the largest vari-
ability in composition and primary sequence. It con-
 .sists of one larger SdhCrFrdC; 23–30 kDa or two
smaller hydrophobic polypeptides SdhCrFrdCr
C rQPs1 and SdhDrFrdDrC rQPs2; 13–18II-3 II-4
.kDa and 11–16 kDa and contains either one or two
protoheme IX groups, with hexa-coordinated iron, or
no heme at all. Anchors with two polypeptides con-
Fig. 1. A schematic outline of succinate:quinone oxidoreductase.
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taining two hemes are denoted Type A, those com-
prising one polypeptide and two hemes — Type B,
two polypeptide anchors with one heme group are
denoted Type C whereas anchors with two poly-
peptides and no heme are referred to as Type D. In
spite of the differences, these SQR and QFR mem-
brane anchors share a common origin, based on
recent evidence to be discussed later.
 .Succinate dehydrogenase EC 1.3.99.1 activity
w xwas first detected in frog tissue in 1909 1 . Since
then a lot of information about the enzyme has been
accumulated. Many review articles with emphasis on
various aspects of the topic are currently available,
w x w xcf. those by Kroger, 2 , Hederstedt and Rutberg, 3 ,¨
w x w xOhnishi and Salerno, 4 , Beinert and Albracht, 5 ,
w x w x w xSinger and Johnson, 6 , Hatefi, 7 , Cole et al. 8 ,
w x w xVinogradov, 9 , Ohnishi, 10 , Jaramillo and Es-
w x w x w xcamilla, 11 , Kita et al. 12 , Kroger et al. 13 ,¨
w x w xAckrell et al. 14 , Hederstedt and Ohnishi, 15 , van
w xHellemond and Tielens 16 and Hagerhall and Hed-¨ ¨
w xerstedt 17 .
w xVinogradov 9 expressed his love for this enzyme
when he wrote ‘‘The history of the study of succinate
dehydrogenase is associated with the names of such
prominent biochemists as D. Keilin, O. Warburg,
L.S. Stern, J. Hopkins, D. Green, R. Morton, M.
Dixon, E. Slater, T. King, T. Singer, H. Beinert and
their students. It is therefore not surprising that the
study of succinate dehydrogenase led to the formula-
tion of a number of concepts which have become
classical in enzymology and have given rise to the
development of whole areas of present day biochem-
w xistry.’’ Singer and Johnson 6 , a year earlier, put the
emphasis on the hard work invested when they state
that their review ‘‘traces the tortuous path, the many
pitfalls and false leads, which have led us from the
discovery of non-heme iron and bound flavin in the
enzyme to elucidation of their structures’’. More
recently, the combination of molecular genetics, bio-
chemistry and biophysical techniques have acceler-
ated progress and improved our understanding of the
enzyme. Nevertheless, Complex II is not a coupling
site in the respiratory chain, and has thus received
less attention than the other mitochondrial respiratory
complexes.
It is notable that Complex II has the same general
composition in pro- and eukaryotes, in contrast to
Complex I, III and IV where, in higher organisms,
various numbers of subunits are present in addition to
those corresponding to the prokaryotic ‘minimal
functional units’ of the enzymes. Saraste coined the
expression ‘Complex I is complex but Complex II is
complex too’ perhaps in response to Ohnishi’s ‘Com-
w xplex I — the most complex Complex’ 18 . Consider-
ing the relatively simple function of SQR it is indeed
a remarkably complex enzyme. For example, the
bacterial NADH:quinone reductase Type II, which
have a similar function in the sense that it is a
non-energy coupled enzyme that carries electrons
from a substrate to quinone, consists of a single
w xpolypeptide with one FAD as a cofactor 19 . The
unique position of Complex II as member of both the
citric acid cycle and the respiratory chain implies that
it may have a key regulatory role. Succinate:quinone
oxidoreductases are also particularly interesting as
model systems to further understand directionality of
long range electron transfer, since they illustrate how
the same components and structure are tuned to carry
out reverse reactions. No high resolution structural
data of SQRrQFR is currently available, although
structural data for one SQR and one QFR may be-
come available in the nearest future.
2. Scope of review
The material in this review is assembled with a
bias towards the authors own research interests. Even
so, I have attempted to focus on the most recent
progress in the field, and to provide comprehensive
structural and functional comparisons of SQRs and
QFRs from different sources. Such a compilation of
currently available data is particularly useful when
X-ray crystallographic structural information be-
comes available for the enzyme from one or a few
species. Progress in the field during the last few years
makes it possible to better understand the functional
directionality of these enzymes, and to propose new
models related to their current function and past
evolution. The ‘respiration early’ hypothesis, which
is based on sequence analyses of terminal oxidases
and other respiratory enzymes, convincingly argues
an early origin of terminal oxidases and other respira-
tory chain components prior to oxygenic photo-
w xsynthesis 20,21 . Although this theory is quite differ-
ent from that converse, more widely accepted and
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presented in textbooks, I am sure that many members
of the scientific community just like myself find it
both logic, plausible and attractive. SQRrQFR from
all species, archaebacteria, eubacteria and eukaryotes
also seems to have a common origin, and was pre-
sumably present in the last common ancestor. It
follows from the ‘respiration early’ hypothesis that
the primordial enzyme was not necessarily a fumarate
reductase. The puzzling complexity of SQRrQFR,
and the large variability particularly in the membrane
anchor domain can be better explained as a develop-
ment of an enzyme with a more complex function to
enzymes with simpler functions. The current succi-
nate:quinone oxidoreductases can be divided into
three functional classes, with a varying degree of
complexity that will be discussed in this context.
Furthermore, I will place a particular emphasis on the
nature of two quinone binding sites in SQRrQFR,
and propose a common framework on which future
experiments can be based.
3. Organization of the sdh and frd genes
In most prokaryotes the genes encoding the
SQRrQFR subunits are organized as an operon. The
first genes to be cloned and sequenced were those for
Escherichia coli QFR. These genes where named frd
A, frdB, frdC and frdD, and encode FP, IP and the
two membrane anchor polypeptides, respectively
w x22,23 . When the operon encoding E. coli SQR was
sequenced the A, B, C, and D nomenclature was kept
for each polypeptide, and the operon became sd-
w xhCDAB 24,25 . The same gene order was found for
w xthe sdh operon in Paracoccus denitrificans U31902 ,
w xCoxiella burnettii, 26 and other gram-negative bac-
teria. In Bacillus subtilis, Bacillus macerans and
Wolinella succinogenes, which have only three sub-
units in SQRrQFR, the gene order is sdhC, sdhA,
w x w x w xsdhB 27,28 Y08563 and frdC, frdA, frdB 29,30 ,
respectively. In Thermoplasma acidophilum sdhB is
followed by sdhC and sdhD, the location of sdhA is
w xunknown 31 . Another archaebacterium, Na-
tronobacter pharaonis contains a sdhCDBA operon
w xY07709 . It appears that regardless of whether the
operon encodes a SQR or a QFR the gene for FP is
always located upstream of that for IP, with the
exception of N. pharaonis. The genes encoding the
membrane anchor polypeptides are however always
clustered and in the order C, D, either before or after
the genes encoding FP and IP. Haemophilus influen-
w x w xsae P44891 , Proteus ˝ulgaris P20921 and My-
w xcobacterium tuberculosis Q10760 contain an operon
similar to the E. coli frd operon. The exceptions are
 .cyanobacteria Synechosystis where two genes ho-
wmologous to sdhB and one to sdhA sll1625, sll0823,
xslr1233 were found flanked by other genes, and
Methanococcus jannashi where one sdhA and one
w xsdhB MJ0033, MJ0092 have been assigned so far,
located apart and surrounded by unrelated genes.
In eukaryotes the FP, IP and the anchor poly-
peptides are generally encoded by unlinked nuclear
w xgenes, cf., 32–35 and imported into the mitochon-
drion. Very recently it was found that the mitochon-
drial genomes of the photosynthetic red algae Por-
phyra purpurea, Chondrus crispus and Cyanidium
caldarium, the zooflagelate Rectinomonas americana
and the liverworth Marchantia polymorpha carry
w xsdhC and sdhD and in some cases also sdhB 36,37 .
In P. purpurea and R. americana the sdhC and
sdhD genes are arranged as in bacteria, whereas in C.
crispus and M. polymorpha they are separated.
The many ongoing, large scale genome sequencing
projects are providing us with SQR and QFR se-
quence information from various organisms. Unfortu-
nately the usefulness of these data is limited, since in
many cases no biochemical data exists for the corre-
sponding enzymes. In other cases, when more than
one set of genes are found, for example in the case of
Saccharomyces cere˝isiae sdhA and sdhC, it is un-
clear which genes to assign to the previously charac-
terized enzyme. Nevertheless, the information is wel-
come since sequence comparisons in many cases
allow us to make some predictions about the unchar-
acterized enzymes. Since user-friendly databases and
search engines are readily available I will not attempt
to provide a complete listing of available SQRrQFR
sequences. The number of sequences, particularly
from various eukaryotes, grow rapidly and a listing
would very soon become outdated. Instead I have
tried to provide sequence comparisons emphasizing
differences rather than similarities, showing a few
typical sequences from each type of SQRrQFR.
These comparisons will by discussed throughout the
text. Presented sequence data are generally referred to
by accession number, for the readers convenience.
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4. SQR and QFR enzyme activity
The two ‘half cell reactions’ of SQRrQFR are:
q y fumarate q 2H q 2e “ succinate E s q30m
.mV
q y quinoneq2H q2e “quinol E sy75 mV tom
.  .q120 mV see Table 1, Fig. 2
In vitro, SQRs and QFRs can generally catalyze
both succinate oxidation and fumarate reduction, but
at different rates. However, in the in vitro assays of
Fig. 2. Structures of naturally occurring quinone substrates, quinone analogues, inhibitors and other compounds commonly used in
 .  . w x .SQRrQFR studies. The E of ubiquinone A is q112 mV and of menaquinone B y74 mV 77 and references therein , asm
w xdetermined in organic solvent. The E of the menaquinone pool in the membrane of Bacillus PS3 is y60"20 mV 170 . The E ofm m
w xrhodoquinone is y63 mV according to 51 . The redox midpoint potential of caldariellaquinone was determined as q100 mV at pH 6.5
w x w x132 . Thermoplasmaquinone is a methylated menaquinone 171 , presumably with a similar E . TTFA stands for theonyltrifluoroacetone.m
 .Carboxin 5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilide is a systemic fungicide of which the 3-methyl derivative is often used as
 .SQR inhibitor. HQNO stands for 2-n-heptyl-4-hydroxyquinoline N-oxide. Phenazinemethosulphate PMS and 2,6-dichlorophenolindo-
 . phenol are redox dyes. DPB 2,3-dimethoxy-5-methyl-6-pentyl-1,4-benzoquinone is a ubiquinone analogue whereas DMN 2,3-dimethyl-
.1,4-naphtoquinone is a menaquinone analogue.
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Table 1
A summary of properties of selected SQRsrQFRs
Thermoplasma Bacillus subtilis Wolinella suc - Micrococcus Escherichia coli Bos taurus Ascaris suum Escherichia coli Saccharomyces
acidophilum cinogenes luteus cere˝isiae
a a q - q -Type of aerobic , aerobic , G anaerobic, G in aerobic, G , facultative G , mammal, parasite facultative, bakers yeast
y .   .organism thermo- and aci- soil bacterium rumen of herbi- found on hu- gut bacterium mitochondria worm muscle G , gut bac- mitochondria
.dophilic archae- vores man skin mitochondria terium
bacterium
Function SQR, Class 3 SQR, Class 3 QFR Class 2 SQR, Class 3? SQR Class 1 SQR, Class 1 QFR Class 2 QFR Class 2 SQR or QFR?
 Sequence sdhBCD loca- sdhCAB frdCAB not available sdhCDAB sd h A sd h B sd - frd A frd D A . frdABCD sd h A ; C h r .
)data tion and se- hCsdhD not suum also con- XI,sdhA ; Chr.
. .quence of sdhA clustered tains an SQR X, sdhB ; Chr.
.is unknown VII,sdhC; Chr.
)XI,sdhC ; Chr.
XIII,sdhD; Chr.
IV
Polypep- 4, 3, 3, 4, 4, 4, 4, 4, 4,
tides:
number ?; 26; 15; 13 65; 28; 23 kDa 79; 31; 25 kDa 72; 30; 17; 15 64; 27; 14; 13 70;27;15;13 kDa 66;27;12;11 kDa 69;27;15;13 kDa 67;27;17;17 kDa
and mass kDa kDa kDa
Membrane Type A Type B Type B Type A or C? Type C Type C Type C Type D Type D
anchor
cQuinone : thermoplasma menaquinone menaquinone menaquinone ubiquinone ubiquinone rhodoquinone menaquinone ubiquinone
type and quinone b, y74 mV y74 mV y74 mV q113 mV q113 mV y63 mV y74 mV q113 mV
E low Em m
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FAD ? present y20 mV present present y79 mV present y55 mV presentcov
w x 2Fe-2S q68 mV at pH q80 mV y59 mV q70 mV q10 mV "0 V ? y20ry79 mV Cys-motif
 . .S1 5.5
w x 4Fe-4S y210 mV at y240 mV y250 mV y295 mV y175 mV y260 mV ? y320 mV Cys-motif
 . .S2 pH 5.5
w x 3Fe-4S q60 mV at pH y25 mV y24 mV q10 mV q65 mV q60 mVrq ? y50ry70 mV Cys-motif
 . .S3 5.5 120 mV
Heme b q75 mV q16 mV y20 mV present q36 mV y185 mV y34 mV absent absentH
Heme b y150 mV y132 mV y200 mV present? absent absent absent absent absentL
Inhibitor HQNO HQNO not sensitive to ? HQNO TTFA, carboxin not sensitive to HQNO ?
dsensitivity TTFA, carboxin TTFA
or HQNO
w x w x w x w x w w x w x w x w xRefer- 31,139,173 27,28,56,66,39 29,30,79,174 175,176 25,24,177– 75,112,135 , 48,64,164,185 22,23,76 , 34,187,188 ,
x w x w x w xences: 179 . 180–184 , 177,186 P3342
w xU50987
a Thermoplasma acidophilum is a chemoheterotrophic aerobic archaebacterium with growth optimum at pH 2 and 598C, but it can also grow anaerobically by sulfur respiration. B. subtilis can
grow anaerobically with nitrate as electron acceptor.
b  w x.Thermoplasmaquinone is a methylated menaquinone see Fig. 2 in 171 .
c w x .The E values stated for ubiquinone and menaquinone are determined in solvent 77 and references therein . The E of the menaquinone pool in the membrane of Bacillus PS3 ism m
w x w x  .y60"20 mV 170 . The E of rhodoquinone is from 51 see also Fig. 2 .m
d w xUnfortunately, there are few systematic studies of SQRrQFR inhibitor sensitivity. For HQNO many are listed in 159 . For other references, see text.
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succinate:quinone oxidoreductase activity directional-
ity is usually achieved by providing the enzyme with
excess substrates, and a quinone with a favorable
redox potential.
Q and Q H bind preferentially to the reduced2 2 2
 .enzyme with dissociation constant k values of 0.3D
w xand 0.9 mM, respectively in the bovine enzyme 14 .
As mentioned, SQRrQFR activity assays involve the
use of quinones or other redox compounds that pro-
vide an energetically favorable reaction. The succi-
nater fumarate couple has a E of q30 mV. Them
commonly used artificial electron acceptor
 .phenazinemethosulfate PMS, Fig. 2 has an E ofm
q80 mV. In assays of SQR activity using PMS,
dichlorophenolindophenol DCPIP, E sq220 mV,m
.Fig. 2 serves as final electron acceptor. DCPIP can
also be used in combination with water soluble
quinone analogues. In the presence of excess DCPIP
the concentration of quinol will be very low through-
out the assay. When quinone reduction is measured
directly, using the different extinction coefficients for
oxidized and reduced form of the quinone in the UV-
region, quinol will accumulate in the cuvette during
the assay. Thus, assays without DCPIP often gives
lower apparent turnover numbers, most likely reflect-
ing product inhibition of enzyme activity due to the
similar k ’s for quinone and quinol. Product inhibi-D
tion may affect the assay more or less severely
depending on assay conditions and instrumentation,
i.e., ability to monitor the initial rate. It should also
be noted that there are cases were electron transfer
from quinol to DCPIP was found to be rate-limiting.
The rate of quinone reduction by bovine SQR mea-
sured with DCPIP was only 75% compared to that
using N, N, N X, N X-tetramethyl-p-phenylenediamine
 .Wurster’s Blue as terminal electron acceptor, or the
initial rate observed when quinone reduction was
w xmonitored directly 38 . The efficiency of DCPIP or
other terminal electron acceptors may also vary de-
pending on the quinone being used as primary accep-
w xtor 39 . QFR activity measurements encounter a
similar problem, i.e., accumulation of oxidized
quinone, and in addition the technical problems with
anaerobic handling of the assay. A new QFR activity
assay method that avoids these problems was de-
w xsigned by Kotlyar et al. 40 and Grivennikova et al.
w x  . 41 , using NAD P H-quinone reductase DT-di-
.aphorase to continuously regenerate quinol.
The in vitro conditions poorly reflect the different
substrate availabilities in the cell. SQR is a member
of the citric acid cycle, that influences the production
of succinate and the removal of fumarate whereas for
QFR, in a cell respiring on fumarate, one has to
expect more accumulation of succinate inside the
cell. In the former case quinol is consumed by the
respiratory chain at some rate, and in the latter case
quinol is being produced at some rate, by various
hydrogenases and dehydrogenases. In addition, DmqH
can influence turnover rates in a positive sense, as
will be discussed later, a condition more difficult to
reproduce in vitro. Furthermore, one has to bear in
mind the difficulties of estimating the actual working
concentrations of quinones or inhibitors in the assays
since these compounds often are hydrophobic and
will accumulate to various degrees in lipid or deter-
gent phase. Thus, turnover numbers from in vitro
activity assays of SQRsrQFRs from different labora-
tories will not be presented since the assays are
performed using different protocols and conditions,
which hampers a meaningful comparison. In general,
results from in vitro activity assays must be inter-
preted with caution, since they in many respects
poorly reflect the in vivo conditions.
A difference in behavior of SQR and QFR was
 .seen in the direct unmediated catalytic electrochem-
istry of the FPrIP subunits from bovine mitochondria
w x w x42 and E. coli QFR 43 when adsorbed on an
electrode surface, i.e., cyclic voltammetry experi-
ments. For the SQR it was found that catalysis in the
direction of fumarate reduction was controlled by a
potential gating effect, with activity decreasing as the
electrochemical driving force is increased. No such
effect was seen with the QFR. The fumarate reduc-
tase activity of SQR was maximal at y85 mV.
Recently, a more detailed study of the B. taurus
FPrIP showed that the two electronrtwo proton
reduction of FAD most likely is responsible for the
tunnel diode effect. Furthermore, binding and release
of the competitive inhibitor oxaloacetate is observed
 .when cycling between FAD tight binding andox
 . w xFAD weaker binding 44 . This will be furtherred
discussed in Section 7.2.
A similar contrasting behavior of SQR and QFR
can be seen in assays where fumarate reduction is
measured using benzyl viologen radical E sy359m
.mV as electron donor. The fumarate reductase activ-
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ity of a number of QFRs decreases as expected when
 .the substrate electron donor concentration becomes
lower whereas for a number of SQRs the activity
increases. Notably, the SQR of B. subtilis, that do
not support fumarate respiration in vivo, behaved in
w xthis assay as a QFR enzyme 45 . This method was
later used to compare a number of eukaryotic succi-
nate:quinone oxidoreductases. The ‘diode’ behavior
was observed in rat and bovine heart SQR, in the
facultative anaerobic organisms Mytilus edulis mus-
.  .sels , Crassostrea angulata oysters and Arenicola
 .marina lugworms , and in aerobic, free living life
 .stages of Fasciola hepatica metacercariae and
 .Haemonchus contortus L3 but was also seen in the
anaerobic life stages of Ascaris suum and F. hepat-
ica, although both these organisms completely de-
pend on QFR activity. Adult H. contortus and Dicty-
ocaulus ˝i˝iparus on the other hand, which are not
solely dependent on fumarate reductase activity do
w xnot show the ‘diode’ behavior 46 . Thus the absence
or presence of ‘diode’ behavior seems to give no
indication to the importance of fumarate reduction in
vivo.
5. Succinate oxidation and fumarate reduction are
generally carried out by separate enzymes in vivo
Some succinate:quinone oxidoreductases, i.e., those
w x w xof Desulfobulbus elongatus 47 and A. suum 48 ,
have been suggested to function as both SQR and
QFR in vivo. In the case of D. elongatus this conclu-
sion was based on the fact that the same apparent Km
values for succinate oxidation and fumarate reduction
were observed in crude cell extract and in a purified
enzyme. Furthermore, resting cells of Db. elongatus
grown on a lactate-sulfate medium can oxidize propi-
onate and produce propionate from lactate without
any lag. In the case of A. suum it was more recently
shown that both the parasitic nematodes A. suum and
H. contortus contain different, growth stage specific
w xforms of succinate:quinone oxidoreductase 49,50 . In
addition, these and other eukaryotes were shown to
 .switch from the use of ubiquinone E q112 mV tom
 w x .rhodoquinone E y63 mV, 51 , Fig. 2 as electronm
w xcarrier under anaerobic conditions 46 . Other organ-
isms, such as E. coli, have long been known to have
a SQR and a QFR expressed during aerobic and
w xanaerobic growth, respectively 52 , the former using
ubiquinone and the latter using menaquinone as elec-
w xtron acceptorrdonor 53 . Some controversy remains
as to whether these enzymes can substitute for each
w xother in vivo 54 .
Bacillus macerans belonging to the B. polymyxa
.group of the Bacilli contains only menaquinone
regardless of growth condition, but was shown to
express different succinate:quinone oxidoreductase
w xenzymes during aerobic and anaerobic growth 55 .
Bacillus subtilis and other members of the B. sub-
. w xtilis subgroup also contains only menaquinone 56
and can grow anaerobically only by nitrate respira-
tion, and not by fumarate respiration. B. subtilis
contains one SQR and in vitro it exhibits higher
fumarate reductase rates than succinate oxidation
rates, when provided with quinones with a favorable
w x w xredox potential 39,57 . Schirawski and Unden 55
concluded that the potential fumarate reductase activ-
ity of the B. subtilis SQR must somehow be inhibited
in vivo.
As mentioned, the DNA sequencing efforts in S.
cere˝isiae has so far identified two genes homolo-
gous to those encoding FP, one for IP, two for SdhC
wand one for SdhD Z28148x1, Z49320x1, J05487x1,
xZ28141x1, Z49702x19, Z46727x11 . Some SQR ac-
tivity remained in a yeast sdhD knockout mutant
w x58 . Thus it is possible that yeast also contains a
SQR and a QFR expressed under different growth
conditions. Other organisms also contain multiple
sets of postulated SQRrQFR encoding genes, but no
information is available as to whether they are func-
tional genes. A search for a gene causing a respira-
tory chain deficiency in man turned up two sdhA
genes, one on the distal long arm of chromosome 3
and the other on the distal short arm of chromosome
5. Only the latter gene was expressed in the somatic
w xcell hybrids tested 59 , but the authors conclude that
both genes may still be functional and could be
tissue-specific andror developmentally regulated. If
so, they may be responsible for the clinical hetero-
geneity of SQR deficiency in humans.
It must be concluded that SQR and QFR are
functionally distinctly different enzymes in spite of
similarities in structure and composition. To vary the
quinone type in the membrane from ubiquinone to
menaquinone or other low potential quinones facili-
tates, but is apparently not enough to turn a SQR into
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a QFR. It is probably the rule more than an exception
that organisms carry a separate enzyme for each of
the two functions. Thus, intrinsic properties must
determine whether a succinate:quinone oxidoreduc-
tase functions as SQR or QFR.
6. Three functional classes of succinate:quinone
oxidoreductases
A compilation of available information for se-
lected, relatively well characterized succinate:quinone
oxidoreductases is provided in Table 1. To be able to
rationalize these data it is helpful to have a functional
classification of the enzymes. SQRs and QFRs in
different organisms can be divided into three func-
 .tional classes Fig. 3 , based on the quinone substrate
and the in vivo function of the enzyme.
Class 1. SQRs that in vivo catalyze oxidation of
succinate and reduction of a high potential quinone
such as ubiquinone. Enzymes of this class are com-
mon, and are often perceived as typical. They are
found in mammalian mitochondria and also in many
other pro- and eukaryotes.
Class 2. All QFRs so far studied are included in
Fig. 3. The cartoons and graphs illustrate electron transfer in three principally different enzyme classes of SQRrQFR. Examples of Class
 .  .1 enzymes are E. coli SQR filled circles and B. taurus SQR open triangles transferring electrons from succinate to ubiquinone.
 .  .Examples of Class 2 enzymes are W. succinogenes QFR filled circles and E. coli QFR open triangles transferring electrons from
menaquinol to fumarate. These enzymes are chosen as representatives of somewhat different members of Class 1 and 2 respectively see
.text and Table 1 . The Class 3 enzyme is B. subtilis SQR, catalyzing oxidation of succinate and reduction of menaquinone. Reference to
the various E values can be found in Table 1. The low potential iron-sulfur cluster S2rFR2 have been omitted from the plots for clarity.m
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this class. They always catalyze oxidation of a low
potential quinol such as menaquinol or rhodoquinol
and reduction of fumarate.
Class 3. SQRs that in vivo catalyze oxidation of
succinate and reduction of a low potential quinone
such as menaquinone or thermoplasmaquinone. This
class of enzyme is found in B. subtilis, B. macerans,
T. acidophilum and seemingly in other gram-positive
bacteria and archaebacteria using exclusively low
potential quinones in the respiratory chain.
As seen in Table 1 and Fig. 3, and as will be
further discussed, the midpoint redox potentials of the
iron-sulfur clusters are differently tuned in the three
enzyme classes. In addition, the Class 3 SQRs seem
to predominantly contain membrane anchors of Type
A and B, i.e., membrane anchors that contain two
transmembraneously arranged hemes, whereas Class
1 and 2 enzymes contain membrane anchors of vari-
ous types. The Class 1 and Class 2 enzymes both
carry out reactions that are energetically favorable,
i.e., involve an overall decrease in DG. Class 3
 .enzymes are catalyzing an ‘uphill’ reaction Fig. 3 ,
i.e., the final electron acceptor has a lower reduction
potential than the succinaterfumarate couple. Thus
the functional mechanism of these SQRs deserve
special attention. So far we have failed come up with
any convincing explanation to what prevents exten-
sive electron ‘back flow’ in these SQRs, when the in
vitro assays predict a large bias towards fumarate
reduction in these enzymes.
B. subtilis SQR, a Class 3 enzyme, can be readily
overexpressed without any apparent growth impair-
ment of the cells. An effect on cell growth would be
expected if a delicate balancing of succinate and
Fig. 4. Schematic representation of different conserved segments in the FP polypeptide. The indicated segments a–j are of importance for
FAD binding or part of the active site. The positions of mutations discussed in the text are indicated by flags. Sequences are from N.
 .  .  .  .  .pharaonis Np, Y07709 , B. subtilis Bs, P08065 , W. succinogenes Ws, P17412 , B. taurus Bt, P31039 , A. suum As, D30650 ,
 .  .  .  .Plasmodium falsiparium Pf, D86573 , S. cere˝isiae Sc, Q00711 , Synechosystis sp. Sy, slr1233 , P. denitrificans Pd, U31902 , E.
 .  .  .  .coli SQR EcS, P10444 , E. coli QFR EcQ, P00363 , M. tuberculosis Mt, Q10760 and M. jannashi. Mj, MJ0033 .
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oxidized menaquinone levels facilitate the appropri-
ate reaction.
It should be noted that the succinate to oxygen
respiratory activity of B. subtilis is 13 times lower in
membranes isolated in uncoupled state compared to
in intact bacteria and furthermore, 90% of the respira-
tory activity in intact bacteria was lost upon addition
of small amounts of protonophore tetrachloro-2-tri-
. w xfluoro-methyl-benzimidazol 56 . This indicates that
a mechanism to control directionality is present in the
Class 3 enzymes, and it seems to be associated with
the membrane part of the enzyme.
There is also an important evolutionary aspect to
this issue. The reason for the current, seemingly
unnecessary complexity of Complex II may be that
the primordial enzyme had a more complex function.
The Class 3 SQRs may in this respect closely resem-
ble the last universal ancestor enzyme, whereas the
enzymes of the two other classes represent degener-
ate, simplified forms. This aspect will be further
discussed toward the end of this review. Let us now
take a closer look at the components of
succinate:quinone oxidoreductase.
7. The flavoprotein subunit
 .The flavoprotein FP subunit is a soluble 79–65
kDa polypeptide, exposed on the matrix side of the
mitochondrial inner membrane or the prokaryotic
cytoplasmic membrane. The FP subunit contains the
dicarboxylate binding site. Amino acid sequence
comparisons have revealed several particularly con-
 .served regions in the FP polypeptide Fig. 4 . Oxida-
tion of succinate to fumarate is a trans-dehydrogena-
tion. L-Chlorosuccinate but not D-chlorosuccinate is a
w xsubstrate for SQR 60 . Malonate and oxaloacetate
are not substrates, but potent competitive inhibitors of
SQR, although the sensitivity to oxaloacetate varies
w xgreatly between different SQRrQFR 14 . D- and
L-malate are poor substrates for SQR since they are
oxidized at the active site to enol-oxaloacetate that
w xinhibits the enzyme 61 . More extensive data con-
cerning substrate binding and catalysis as well as
various aspects on the covalently bound FAD can be
w x w xfound in 14 and in 15 . A model for the dicarboxyl-
ate binding site is shown by van Hellemond and
w xTielens in 16 .
7.1. The dicarboxylate binding site
Chemical modifications of substrate protectable
residues in combination with mutant studies have
been used to identify residues in the FP polypeptide
that are located in or close to the active site. B.
taurus SQR, E. coli SQR and QFR and W. succino-
genes QFR are very sensitive to thiol-modifying
reagents and substrate or substrate analogues protect
w xthese enzymes from inactivation 15 and refs.
.therein . B. subtilis SQR is not sensitive to thiol-
modifying reagents. In the former species there is a
 .cysteine residue in segment g Fig. 4 , that is not
conserved in B. subtilis. When the alanine in this
position in B. subtilis FP was changed to cysteine the
SQR remained fully functional, but became sensitive
to thiol-modifying reagents, and could be protected
w xby substrate 62 . Analogously, when the indicated
cysteine in the FP of E. coli QFR was changed to
alanine the enzyme became less sensitive to modifi-
w xcation 63 . A. suum and Caenorhabditis elegans FP
have serine in the place of this cysteine. SQR activity
in these organisms is nevertheless sensitive to
sulfhydryl reagents. A cysteine residue six residues
 .from the serine see Fig. 4 was suggested to be
responsible for the effect. Furthermore, QFR activity
in A. suum was not at all affected by the reagents
w x64 , in contrast to in E. coli QFR and B. taurus
w xSQR 41 . Next to the cysteine in segment g there is a
conserved arginine residue that is suggested to form a
bidentate ionic pair with one of the carboxylate groups
of succinate, thereby orienting the substrate at the
w xactive site 65 . Diacetyl modification of E. coli QFR
suggests that two arginines are functionally important
w x63 . A B. subtilis SQR mutant has one of the
conserved glycines in segment d replaced by a gluta-
mate. This mutant enzyme is inactive although all
prosthetic groups are present and have normal proper-
w x  .ties 66 . Segment f in FP Fig. 4 contains a con-
served triad, H-P-T. An E. coli QFR mutant with the
histidine in this triad replaced by a serine can not
w xoxidize succinate 63 . However, fumarate reductase
activity of this mutant QFR is close to wild type
levels. It has been suggested that an unprotonated
histidine may assist in the deprotonation of succinate
w x67 . The active site of the flavoenzymes glutathione
reductase and lipoamide reductase contain an identi-
w xcal triad motif 15 . The combined data indicate that
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residues in segments f, g and d are part of the
dicarboxylate binding site. Mammalian SQR and E.
coli QFR have different affinities for substrate and
the inhibitor oxaloacetate depending on whether the
enzyme is in the reduced or oxidized state as summa-
w xrized in 14 . This indicates that the structure of the
dicarboxylate binding site must be different depend-
ing on the redox state of enzyme.
A mutation causing SQR deficiency in two human
siblings was shown to be a R555“W substitution in
FP. About 60% of wild type SQR activity was ob-
served in patient cells. The defect Complex II showed
w xincreased sensitivity to oxaloacetate 59 .
7.2. FAD
Segment b contains the histidine residue, to which
 .FAD is covalently bound via N 3 -8a-riboflavin
w xlinkage 68 . The sequence of segment b is not con-
served in other types of enzymes containing His-
 . w xN 3 -8a-FAD 14 , which suggests that this sequence
is more related to enzyme function than FAD bind-
ing. Segments a, h and i are probably in contact with
w x .the AMP part of FAD 14 and references therein . It
is not known by which mechanism the FAD is incor-
porated, but FAD is covalently bound to FP before
w xenzyme assembly 69 . An autocatalytic mechanism
have been suggested. However, B. subtilis SQR ex-
pressed from cloned genes in E. coli is not flaviny-
w xlated 70 . In yeast flavinylation of FP occurs in the
mitochondrial matrix, after import of the polypeptide
and removal of the presequence. FAD attachment
was stimulated by, but not dependent on presence of
w xIP 71 . A matrix processing peptidase, but not any
mitochondrial chaperonins seem required for covalent
w xattachment of FAD 72 .
Succinate oxidation is only possible when the FAD
is covalently bound. Desulfo˝ibrio multispirans QFR
contains non-covalently bound flavin and can not
w xoxidize succinate 73 . Replacement of the FAD-
binding histidine by various amino acids in E. coli
QFR results in mutant enzymes that contain stoichio-
metric amounts of non-covalently bound FAD that
can not oxidize succinate. Some fumarate reductase
activity was retained in the mutants in vivo and in
w xvitro 74 . Sequence data predict that FP from the
anaerobic archaebacterium M. jannashi contains
non-covalently bound FAD and therefore most likely
 .is a component of a QFR Fig. 4 .
The flavin is probably located close to the sub-
strate binding site and the most likely first electron
acceptor during succinate oxidation. In B. subtilis
mutants lacking flavin i.e., a G“D mutation in
.segment b the iron-sulfur centers are not reduced by
succinate, but can be reduced by reversed electron
w xtransfer from menaquinol in the membrane 66,70 .
FAD is a two electron carrier, in contrast to the other
prosthetic groups in SQRrQFR. Redox titrations can
be performed on the flavin free radical EPR signal at
gs2.00. The midpoint potentials of the two consecu-
tive electron transfer steps of FAD in B. taurus SQR
were determined to be y127 mV and y31 mV at
pH 7, corresponding to a midpoint potential of y79
w xmV for the overall reaction 75 . Similar redox poten-
tials for FAD in SQRrQFR have been determined in
 .other species Table 1 . Free FAD has a midpoint
w xpotential of y219 mV 76 . Thus, both electron
transfer steps to enzyme-bound FAD are endergonic
with respect to the succinaterfumarate couple q30
w x.mV; 77 . The FAD free radical state in bovine SQR
y2 w xhas a stability constant of 2.5P10 75 , i.e., it is
much more stable than typical ns2 components
such as free NADqrNADH or QrQH . These2 2
observations indicate that FAD performs the ns2 to
ns1 conversion required to transfer electrons from
succinate to the iron-sulfur clusters and vice versa
within SQRrQFR.
In B. taurus SQR in the presence of succinate a
maximum of 10% flavin free radical was observed at
w xpH 7 and up to 20% at pH 9 75 . In contrast, in
reconstitutivly inactive preparations of the same en-
zyme, i.e., FPrIP lacking iron-sulfur cluster S3, the
w xflavin radical was 80% of maximal at pH 7.8. 78 .
Interestingly, in B. subtilis SQR, and only in the
presence of succinate, we observe a similar, large
flavin free radical in both the membrane bound and
intact, isolated enzyme Hagerhall and Sled’, unpub-¨ ¨
.lished . A flavin free radical showing anomalous
behavior has also been observed in W. succinogenes
w xQFR 79 .
In the previously mentioned cyclic voltammetry
experiments using B. taurus FPrIP it was shown
that the two electronrtwo proton reduction of FAD
most likely is responsible for the tunnel diode effect.
Furthermore, binding and release of the competitive
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inhibitor oxaloacetate is observed when cycling be-
 . tween FAD tight binding and FAD weakerox red
. w xbinding 44 . The ‘diode’ behavior is absent in the
E. coli QFR, but both enzymes are sensitive to
oxaloacetate and exhibit different affinities for the
inhibitior in the oxidized and reduced states. Redox
w x w xtitrations of deactivated SQR 80 and QFR 76
demonstrated that reductive activation results from
reduction of FAD. However, the processes differed
for the two enzymes; activation of B. taurus SQR
involved 2ey and 2Hq, whereas the process requires
2ey and 1Hq in E. coli QFR, consistent with reduc-
tion of the flavin to the anionic hydroquinone form.
The reason for the difference is not understood. The
redox potential of the FADrFADH couple in QFR2
 .E y55 mV, Table 1 is slightly more positive thanm
that in B. taurus SQR.
( )8. The iron-sulfur protein IP subunit
This subunit is 31–24 kDa, and harbors three
iron-sulfur clusters. The IP polypeptide contains three
groups of cysteine residues, which are ligands to
three iron-sulfur clusters. B. subtilis and E. coli
mutant IPs, truncated before and after the second
w xgroup of cysteines respectively, retain the 2Fe-2S
w xcluster but have lost the other two clusters 81,82 .
Thus, IP can be described as consisting of two do-
w xmains. The N-terminal domain harbors the 2Fe-2S
 .cluster S1rFR1 , ligated by a CxxxxCxxC.........C
 .motif, resembling a plant-type ferredoxin Fig. 5A .
w x  .The C-terminal domain ligates the 4Fe-4S S2rFR2
w x  .and 3Fe-4S S3rFR3 clusters and contains cysteine
motifs characteristic for bacterial ferredoxins Fig.
.5B . Information about the spatial organization of the
iron-sulfur centers is provided from EPR:detectable
magnetic spin–spin interactions. The distance be-
˚tween FAD and S1 is 12–18 A, cluster S1 and S2 are
˚9–12 A apart whereas cluster S1 and S3 are esti-
˚mated to be 10–20 A apart. Strong spin–spin cou-
pling also between cluster S2 and S3 has been de-
tected, indicating close mutual distance of these clus-
w xters 10,15 .
Two peculiar exceptions among IPs are the postu-
lated IP from M. jannashi which contains a very
 .long additional tail in the C-terminal end Fig. 6 and
one of the postulated IPs in Synechosystis which also
contains a C-terminal extension, though much shorter
than the one in M. jannashi. The archaebacterial
polypeptide comprises 489 amino acids and the
cyanobacterial 331 amino acids, whereas typical IPs
contain 240–250 amino acids. The deduced amino
acid sequence in the C-terminal part of the M. jan-
nashi polypeptide shows sequence similarity to a
subunit of heterodisulfide reductase, HdrB, from
Methanobacterium thermoautotrophicum Fig. 6
w x.83 . In addition both postulated IP polypeptides
w xcontain cysteine motifs indicative of two 4Fe-4S
clusters, in addition to S1. These polypeptides will be
further discussed in following sections. Apart from in
the former species, the structure of IP in various
organisms seems very well conserved, but the mid-
point potential of the respective iron-sulfur clusters
varies depending on how the enzyme operates Table
.1, Fig. 3 .
w xAckrell et al. 14 give an excellent overview of
the EPR properties of the respective iron-sulfur clus-
ters in SQRrQFR. For a recent review on FeS cluster
containing proteins in general see that by Johnson,
w x84 .
[ ]8.1. The 2Fe-2S cluster
In general, the midpoint potential of S1rFR1 in
w xSQRrQFR is high compared to that of 2Fe-2S
w x w xcenters in plant type ferredoxins 85 . The 2Fe-2S
center of the Rieske protein in the bc complex1
w xFig. 5. A: sequence comparison of the N-terminal domain of IP. The sequence and structure of a plant type ferredoxin 172 is shown as a
w xreference to this domain. The sequence following the 2Fe-2S cluster ligating domain is typical for IP, and is not found in other
iron-sulfur proteins. B: sequence comparison of the C-terminal domain of IP. The sequence and structure of a bacterial type ferredoxin
w x  .94 is shown as a reference. Mutations discussed in the text are indicated by flags. Sequences are from: T. acidophilum, Ta, X70908 , N.
 .  .  .  . pharaonis Np, Y07709 , B. subtilis Bs, P08066 , W. succinogenes Ws, P17596 , E. coli SQR EcS, P07014 , Homo sapiens Hs,
.  .  .  .  .P21912 , P. falsiparium Pf, D86574 , S. cere˝isiae Sc, P21801 , U. maydis Um, P32420 , C. crispus, Ccr, P48932 , Synechosystis sp.
 .  .  .  .Sy1, sll0823, Sy2, sll1625 , M. jannashi. Mj, MJ0092 , E. coli QFR EcQ, P00364 and M. tuberculosis Mt, Q10761 .
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 .Complex III also has a much higher midpoint po-
tential than the clusters in ferredoxins. In the bc1
complex two cysteines and two histidines are ligating
w x w xthe 2Fe-2S cluster 86,87 . The higher midpoint
potential is in this case explained by that nitrogen is
less electron-donating than sulfur.
w x  .The ligation of the 2Fe-2S cluster S1rFR1 has
been studied in detail in E. coli QFR, where the four
w xcysteines were individually changed to serine 88 .
The mutants retained all iron-sulfur clusters, as well
as at least some enzymatic activity. The EPR proper-
ties of cluster FR2 and FR3 were normal in these
w xmutants. It was shown that the 2Fe-2S cluster is
assembled in each of the four mutants, but the muta-
tions cause changes in g tensor anisotropy andror
redox midpoint potential. The potential of the cluster
 .was lower than in the wild type y79 mV in the
 .  .C57“S y182 mV , the C62“S y322 mV and
 .the C77“S y110 mV mutants, but higher than in
 . w xwild type in the C65“S y49 mV mutant 88 . It
should be noted that the third cysteine in the
CxxxxCxxC.....C motif is not fully conserved; the IP
of E. coli and N. pharaonis SQR has an aspartate
whereas M. tuberculosis QFR has a serine in this
 . w xposition see Fig. 5A . Werth et al. 89 concluded
that C65 in E. coli QFR is not essential for function
although it may be a cluster ligand in the wild type
enzyme. They proposed that S1rFR1 is coordinated
by three cysteines and a water molecule, the latter
being hydrogen bonded to an aspartate or a cysteine.
This seems to be an attractive scheme, since it could
explain the higher E of S1rFR1 compared to ferre-m
w xdoxin 2Fe-2S clusters.
The iron-sulfur cluster S1 is most likely the first
electron acceptor after flavin in SQRs and FR1 is the
electron donor to flavin in QFRs. It should be noted
 .that S1 has a high E higher than S3 in Class 3m
 .SQRs, an intermediate E but lower than S3 inm
Class 1 SQRs and a low E in QFRs Table 1, Fig.m
.3 . Growth properties and enzyme activities of the
above mentioned E. coli QFR mutants demonstrated
near wild type properties of the C65“S mutant but
a decreased enzyme activity in the remaining mutants
w x88 perhaps indicative of some redox imbalance.
[ ] [ ]8.2. The 4Fe-4S and 3Fe-4S clusters
w xThe C-terminal part of the IP ligates the 4Fe-4S
w xand 3Fe-4S clusters and contains cysteine-motifs
 .characteristic for bacterial ferredoxins Fig. 5B . As-
suming a ferredoxin-like structure of the C-terminal
part of IP these two clusters are located close to each
other. Attempts have been made to identify the lig-
ands to FR2 and FR3 in E. coli QFR by site-specific
mutagenesis. Replacement of C154, C158, C204,
C210 and C214 by serine resulted in the loss of both
w xFR2 and FR3, but did not affect FR1 90,91 . The
C148“S and C151“S mutants retained all three
clusters, with a modest decrease in E of FR1 andm
 .FR3 about y10 to y15 mV and a somewhat larger
decrease, y60 to y70 mV, of FR2. The mutant
enzymes showed pronounced instabilities and signs
of increased oxygen sensitivity. However, EPR anal-
yses of the C148“S mutation revealed much more
complex resonances for FR2 than in the wild type
enzyme, interpreted as perturbation of the FR2–FR3
intercluster spin–spin interaction. The FR1-FR2
spin–spin interaction was not affected by this muta-
tion. The C151“S mutant lacked resonances other
than those originating from FR1 in the spin 1r2
 .  .Fig. 6. A schematic outline of a classical IP polypeptide A, Figure 5 compared to the postulated IP from M. jannashi B, MJ0092 and
 .the HrdB polypeptide, a subunit of heterodisulfide reductase from M. thermoautotrophicum C, X81133 . Detailed sequences of IP are in
 .Figure 5A and B see also FP from M. jannashi, Fig. 4 . The C-terminal end of M. jannashi IP and HrdB are similar to the SdhC
w x .polypeptide in S. acidocaldarium Y09041 , see text .
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region and exhibited new resonances at gs5.7 and
w x5.0 indicative of a Ss3r2 4Fe-4S cluster. Further-
more, the presence of FR2 was apparent from the
always observed increase in FR1 spin relaxation after
dithionite reduction. It was concluded that FR2 in this
w xmutant is assembled as a 4Fe-4S cluster, but that the
replacement of a cysteinyl ligand with a serinate
ligand causes a change in the spin state of the
w xreduced cluster from 1r2 to 3r2 91 .
When a fourth cysteine residue was introduced
into the putative FR3 binding motif of E. coli QFR
 . w x wV207“C substitution; Fig. 5B , a 3Fe-4S to 4Fe-
x4S cluster conversion occurred, i.e., a mutant en-
w xzyme with two low potential 4Fe-4S clusters was
w xobtained 90 . Opposite cluster conversion, i.e., from
w x w x4Fe-4S to 3Fe-4S , has been reported for several
enzymes after replacement of a ligating cysteine by
 w x.another amino acid cf., 92,93 . These observations
suggest that the prototypical cysteine sequence motif
predominantly determines the cluster type. Taken
w xtogether it can be concluded that the 4Fe-4S
 . w x  .S2rFR2 and 3Fe-4S S3rFR3 clusters both prob-
ably have a cubane-like structure and are ligated by
the cysteine residues arranged in the sequence as
CxxCxxCxxxCP followed by CxxxxxCxxxCP. The
first three cysteines in the first group and the last
cysteine in the sequence are ligands to S2rFR2 and
the remaining cysteines are ligands to S3rFR3, as is
also deduced from sequence comparison to bacterial
ferredoxins that contain cubane iron-sulfur clusters
 w x.Fig. 5B, cf., 94 .
However, when a cysteine was introduced in the
S3 consensus binding motif in IP of B. subtilis
 .S214Q215“CG, Fig. 5B , a tri- to tetranuclear
w xcluster conversion did not occur, and a 3Fe-4S
cluster, with somewhat altered EPR properties re-
w xmained in the enzyme 95 . Thus we concluded that a
cysteine residue in this position in B. subtilis IP is
somehow sterically hindered from acting as a ligand
for a tetranuclear cluster, whereas in E. coli QFR this
is not the case.
As mentioned, two different genes homologous to
sdhB are present in the genome of Synechosystis, and
one in M. jannashi. The deduced amino acid se-
wquence reveals cysteine motifs typical for two 4Fe-
x 4S clusters in the IP homologous polypeptides Fig.
.5B . Unfortunately there is no biochemical informa-
tion about SQRrQFR in cyanobacteria or in M.
jannashi, or experimental evidence indicating whether
either of these polypeptides are components of
SQRrQFR. There are examples of polypeptides that
w xcontain sequence motifs indicative of one 2Fe-2S
w xcluster followed by two 4Fe-4S clusters that are
subunits in unrelated enzyme complexes, for example
RnfB encoded by the Rb. capsulatus rnf-operon
w x96,97 . However, this subunit notably lacks the pep-
tide stretch between the S1rFR1 domain and the
S2rFR2-S3rFR3 domain in IP which is present and
conserved in IPs as shown in Fig. 5A and Fig. 6.
Results from gene fusion experiments in S. cere-
˝isiae have indicated that this particular segment in
IP, located between the first and second cysteine
 .motif Fig. 5A , is important for assembly of SQR
w x98 . Recent sequence information from an other
archaebacteria, Sulfolobus acidocaldarius, provides
explanations to the nature of the M. jannashi IP
which will be discussed towards the end of Section 9.
w xThe 4Fe-4S cluster generally has a very low
potential and may not participate in electron transfer
 .Table 1 . It can however not be excluded that the
determined low potential is an artifact, due to antico-
w xoperative interaction between the redox centers 99 .
w xIt has also been suggested that the 4Fe-4S cluster
functions as a ‘voyeur’ cluster with the purpose of
modifying the wavefunctions of its neighbor clusters
w x100 . The mutagenesis studies in E. coli QFR
demonstrate the important structural role of this clus-
ter. In the C148“S and C151“S mutants there
was only a modest effect on the E of FR2 but am
50–70% decrease in fumarate reductase activity with
DMNH , the substrate most resembling the physio-2
 . w xlogical electron donor Fig. 2 91 .
w xThe 3Fe-4S cluster clearly has an important struc-
tural role, as demonstrated early by reconstitution
studies using B. taurus SQR. Purified, soluble FPq
IP can be rebound to the anchor domain only when
w xcluster S3 is kept intact 101–103 .
In B. subtilis it was shown that the S3 signal, but
not the S1 or S2 signals in wild type SQR, is
extremely sensitive to methanol. Within less than two
minutes in the presence of 1% methanol the lineshape
and power saturation behavior of the S3 signal dra-
matically changed, whereas the midpoint potential of
w xthe cluster remained the same 95 . The effect of
methanol-modification on S3 is seen in membrane
bound as well as in isolated SQR. Interestingly,
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ethanol does not have these effects. The modification
of S3 was reversible, i.e., methanol could be washed
off from the membranes and a near normal S3 signal
was restored. The S3 center of the previously men-
tioned SQ“CG mutant was in contrast completely
insensitive to methanol. The presence of 1% methanol
does not inhibit succinate reductase activity in vitro,
w xusing PMS or Q as electron acceptors 95 . The1
drastic effect of methanol, but not ethanol, on the
properties of S3 can possibly be explained by that
methanol fits into a small pocket, where it affects the
S3 micro-environment. This pocket is then absent or
perturbed in the mutant enzyme, which makes it
completely insensitive to methanol.
There are also several indications that cluster
S3rFR3 is close to a quinone binding site, and
functions as electron donorracceptor torfrom
quinone. This quinone-binding site will be further
discussed in the section on quinone interaction. Gen-
erally, in Class 1 SQRs, interacting with ubiquinone,
the E of S3 is higher than that in Class 2 QFRs orm
in Class 3 SQRs, interacting with low potential
 .quinones Table 1, Fig. 3 .
It was observed early that extraction of ubiquinone
from submitochondrial particles affected the redox
midpoint potential of the so called HiPIP center, later
w xdemonstrated to be cluster S3 104 . Addition of
 .TTFA, a SQR specific inhibitor, Fig. 2 to pigeon
heart submitochondrial particles resulted in not only
quenching of the hyperfine splitting originating from
the semiquinone pair in SQR discussed in detail
.later , increased the EPR signal amplitude of S3, and
shifted its midpoint redox potential by about y50
w xmV 105 . A somewhat larger shift in E was ob-m
served using beef heart submitochondrial particles
w x106 . A mutation in Ustilago maydis SQR, confer-
ring resistance to a similar specific inhibitor, carboxin
was found to be a histidine to leucine substitution
 . w xwithin the S3 ligation motif Fig. 5B 107 .
The previously mentioned E. coli QFR mutant
w xwith two low potential 4Fe-4S centers in the en-
zyme, retained 16–17% of wild type SQR and QFR
activities and 30% of the wild type succinate: PMS
w xreductase activity 90 . From these data one can not
conclude whether the change in the FR3 structure or
redox potential or both these changes together impair
the enzyme function. In the B. subtilis IP the SQ“
CG mutation was sufficiently close to the trinuclear
cluster to alter the EPR properties of the S3 signal,
but did not significantly change the midpoint poten-
 w x.tial of the cluster y25 mV, 66,95 . The enzyme
activity of the mutant SQR is about 40% as compared
to wild type enzyme. Thus this mutant demonstrates
that merely a wild type redox potential is not suffi-
cient to retain function, and amino acid residues in
the putative S3 ligation motif seem to be important
 .for binding quinone Fig. 5B .
Another mutation in the FR3 ligation motif, P159
“Q in E. coli QFR resulted in an oxygen sensitive
enzyme that interestingly could be protected from
succinate induced inactivation not only by anaerobio-
sis but also by separating FPrIP from the membrane
anchor or by the presence of an inhibitor blocking
electron transfer torfrom quinone. It was suggested
that the inactivation of the mutant enzyme occurred
by production of hydroxyl radicals generated by a
Fenton-type reaction. As the substrate-induced inacti-
vation was demonstrated to require the presence of
quinone it was concluded that FR3 must be inti-
w xmately associated with a quinone binding site 108 .
Interestingly, somewhat similar types of quinone
binding sites, in close contact with a cubane iron-
sulfur cluster, seem to be present in several mem-
brane bound enzymes. Two E. coli DMSO reductase
mutants, one with a mutation in the DmsC membrane
anchor, and one with a mutation in the DmsB high
 .potential y50 mV iron-sulfur cluster ligation motif,
were analyzed independently and as a double-mutant.
The DmsC mutant was defective in menaquinone
oxidation whereas the mutation in DmsB caused a
w xtetra- to tri- nuclear conversion of the 4Fe-4S clus-
w xter. The EPR properties of the resulting 3Fe-4S
cluster were affected by the menaquinone-like in-
hibitor HQNO, an effect that was abolished in the
double mutant, indicating a close functional link be-
tween the quinone binding site and the iron-sulfur
w xcluster 109 . Furthermore, DMSO reductase is repre-
sentative of a whole group of iron-sulfur-
molybdoenzymes such as E. coli formate dehydroge-
nase, E. coli nitrate reductases and W. succinogenes
wpolysulfide reductase. Another example is the 4Fe-
x4S cluster N2 in NADH:ubiquinone oxidoreductase
which was shown to be in close contact with a
quinone binding site. The spin–spin interaction be-
tween N2, located close to the membrane surface,
and a stabilized semiquinone, presumably located in a
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membrane-spanning subunit, is EPR detectable as
split peaks of the g s2.05 signal originating from5
cluster N2, with a coupling constant of 1.65 mT,
˚indicating a distance of 8–11 A between the interact-
w xing species 110 .
9. The membrane anchor subunits
The membrane anchor consists of one larger or
two smaller polypeptides. The understanding of the
membrane anchor was confused for a long time due
to the varying number of polypeptides and hemes in
different species and preparations. The anchor poly-
peptides from different species show little apparent
sequence similarity, and can for instance not be
picked out from databases as easily as FP and IP
sequences, using conventional comparison programs
 w x.cf. 31 . Recently, an increasing amount of experi-
mental data as well as sequence information made it
possible to clarify some of the confusion. As men-
tioned in the introduction, at our present state of
knowledge there are four types of SQRrQFR mem-
 .brane anchors Table 1, Fig. 7A : Type A anchors
have two polypeptides, with three transmembrane
helices each, and contain two protoheme IX molecules
denoted heme b and heme b , indicating a highH L
.and a low redox midpoint potential respectively .
Type B anchors have one polypeptide with five trans-
membrane helices and contain heme b and hemeH
b . Type C anchors have the same polypeptide ar-L
rangement as Type A, but contains only one proto-
heme IX molecule, corresponding to heme b al-H
though its midpoint potential varies in different or-
ganisms. Type D membrane anchors have two poly-
peptides, with three transmembrane helices each, and
are without heme. We have recently shown that the
four different types of anchors have a common ori-
gin, and presented a three-dimensional structural
model for the membrane-spanning part of the enzyme
w x17 . The structural model is schematically shown in
Fig. 7A, and is based on sequence comparisons in
combination with experimental data.
9.1. Transmembrane topology
Surface labeling experiments using mammalian and
B. subtilis SQR in situ demonstrated that the anchor
w xdomain spans the membrane 111–113 . Neverthe-
less, even recent textbook illustrations of the respira-
tory chain often represent Complex II as membrane
bound, but not membrane-spanning. Hydropathy
analyses of available sequences reveal three hy-
drophobic stretches per polypeptide in the Type A, C
and D membrane anchors whereas five such stretches
are present in the Type B anchors. Their respective
orientation in the membrane can be predicted using
w xvon Heijnes ‘positive inside rule’ 114 . By analyzing
various B. subtilis truncated SdhC with alkaline
w xphosphatase fused at the C-terminal ends 115 it was
demonstrated that this anchor polypeptide contains
five transmembrane segments as predicted, with the
w xN-terminal exposed to the cytoplasm 116 . This
transmembrane arrangement is further supported by
effects of a B. subtilis SdhC mutation, G168“D,
 .Fig. 7C . Residue 168 is located in a hydrophilic
stretch facing the cytoplasm, and the mutation blocks
binding of FP and IP to the membrane anchor, al-
though the cytochrome is assembled, and shows nor-
w xmal spectroscopic properties 117 .
9.2. Heme b and heme b axial ligandsH L
EPR and near infrared MCD spectroscopic infor-
mation suggested bis-histidine axial ligation of both
hemes in B. subtilis SQR, with a near perpendicular
w xorientation of the imidazoles at each heme 118 . The
same type of axial ligation was demonstrated for the
w xsingle heme in B. taurus SQR 119 . The authors of
the latter work further concluded that observed
changes in EPR properties of the isolated cytochrome
was due to perturbation of the orientation of the
imidazole rings, rather than a change in axial ligation
during isolation.
The six histidines present in the B. subtilis SdhC
subunit were individually changed to tyrosine by
site-directed mutagenesis. H47 could be excluded
from consideration as a heme ligand, since this mu-
w xtant assembles SQR with normal properties 120 .
The H13“Y mutant was shown to assemble a SQR
containing two hemes, albeit with somewhat different
w xproperties 116 . The remaining four mutants did not
assemble SQR. H70 and H155 mutant cytochromes
were most severely affected and showed great insta-
bility whereas the H28 and H113 mutant cy-
tochromes could be expressed in E. coli and isolated.
They were found to contain one heme. Taken to-
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gether with the topological data it could be concluded
that H70 and H155, which are conserved in all heme
containing anchors are the axial ligands to heme bH
and H28 and H113, which are conserved in Type A
and B anchors, are axial ligands to heme b Fig. 7,L
w x.116 .
9.3. Heme is important for assembly and stability
Heme has an important role for proper assembly of
the membrane anchor, a prerequisite for binding of
the FP and IP subunits. It was demonstrated already
in 1980 that heme is essential for assembly of B.
( )C. HagerhallrBiochimica et Biophysica Acta 1320 1997 107–141¨ ¨ 127
subtilis SQR. In the absence of heme the apocy-
tochrome is made and inserted in the membrane
whereas FP and IP accumulate in the cytoplasm. The
prosthetic groups seem to be incorporated before
assembly. When heme becomes available, there is
w xassembly of SQR from the preformed subunits 121 .
B. subtilis mutants lacking one or both hemes in the
w xmembrane anchor can not assemble SQR 116,120 .
Recently, the importance of heme for proper assem-
bly was indicated also for a Type C anchor, that of
E. coli SQR. Overexpression of the sdhCDAB operon
in an E. coli mutant deficient in heme synthesis
resulted in accumulation of FPrIP in the cytoplasm
w x122 . Furthermore, this study clearly demonstrated
that although overexpression of SdhD alone results in
an increase in the cytochrome b content of the E.
coli membrane, this cytochrome showed other prop-
erties than that of the wild type cytochrome, and it
was unable to bind FP and IP. Both SdhC and SdhD
were required for heme insertion and assembly of a
functional SQR, i.e., indicated that one ligand to
heme is provided by each polypeptide. These data
add further support to the current assignment of heme
 .axial ligands in Type C anchors Fig. 7 .
9.4. A structural model for the membrane anchor
From the accumulated data it became clear that the
Type A and B anchors are cytochromes with a novel
type of heme arrangement, distinctly different from
that of the diheme cytochrome b of the bc and b f1 6
complexes. The heme axial ligands in SQRsrQFRs
are distributed on four transmembrane helixes instead
of on two. Based on the transmembrane topology and
the position of the four heme axial ligands in B.
subtilis SdhC only three different 3-dimensional folds
remained possible for the core four helix bundle of
that anchor. One is clearly favored and can be applied
 .to membrane anchors of Type A, B, C and D Fig. 7 .
The model was described in a very recent mini-re-
w xview 17 and will thus be discussed more briefly
here. Please bear in mind though, that Fig. 7A com-
prises a schematic illustration of the membrane an-
chors to clearly illustrate the topology of the trans-
membrane helices and the ligation of heme. In the
actual protein the helices in the bundle are probably
somewhat tilted, both relative to the membrane plane
and to each other.
 .Primary sequence comparisons Fig. 7B,C in
which the predicted heme axial ligands andror hy-
drophobic stretches were first aligned and fixed turned
out to be very informative compared to conventional
alignment methods. First, it is clear that the Type B
anchors arose from a fusion of SdhC and SdhD into
one polypeptide, with concomitant loss of helix III.
The shared sequence motifs of the two membrane
anchor polypeptides and the order of their corre-
sponding genes, C and D, in the prokaryotic sdh and
frd operons, indicate that they have resulted from a
gene duplication. An evolutionary early membrane
anchor having the proposed three-dimensional struc-
ture, could have been composed of two identical
subunits encoded by one gene. The heme ligation in
such a homodimer would be the same as in the
existing heterodimers. Additional functions may be
better accomplished when some asymmetry of the
domain is allowed, i.e., in a heterodimer. The
polypeptide fusion in the Type B anchors may have
provided an advantage, for example if the C and D
polypeptides were very similar, and could combine in
the form of CC or DD by mistake. Notably, and as
mentioned before, overexpression of SdhD alone in
w xFig. 7. A: proposed structure of the membrane anchor domain of SQRrQFR. This illustration is adapted from 17 . B: sequence
w xcomparison of SdhC anchor polypeptides. Positions of mutations in E. coli QFR 130 are indicated at the bottom row, and roughly rated
as x for mutations resulting in QFR enzyme with 60% or less enzymatic activity compared to wild type, and o for mutations causing a
smaller or no effect. Other mutations discussed in the text are indicated with flags. Larger flags denote heme axial ligands, and a peptide
 .photo-labeled with a quinone analogue see text . C: sequence comparison of SdhD polypeptides. Mutations and heme axial ligands are
 .indicated as in B . Note that for the Type B anchors the SdhC polypeptides continue from Figure 7B. Sequences are from: B. subtilis
 .  .  .  . Bs, P08064 , W. succinogenes Ws, P17413 N. pharaonis Np, Y07709 , T. acidophilum, Ta, X70908 , B. taurus Bt, P35720,
.  .  .  . U50987 , E. coli SQR EcS, P10466, P10445 , P. denitrificans Pd, U31902 , C. burnettii, Cb, L33409 , Rickettsia prowazekii Rp,
.  w x.  .  w x .  w x.P41085 , R. americana, Ra, 36 , C. caldarium, Cca, P48935, only SdhC , A. suum, As, 164 , only SdhD , P. purpurea, Pp, 36 C.
 .  .  . crispus, Ccr, P48934 , M. polymorpha, Mp, P35721, M68929 S. cere˝isiae Sc, P33421, P37298 , E. coli QFR EcQ, P03805,
.  .  .P03806 , H. influenzae, Hi, P44892, P44891 and M. tuberculosis Mt, Q10762, Q10763 .
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E. coli resulted in production of a cytochrome b
w x122 .
Helices I, II, IV and V, on which the histidine
axial ligands to heme are distributed, form a four
 .helix bundle in the model Fig. 7A . Statistical analy-
ses of the primary sequences for heme-containing
anchors showed that hydrophobic residues are pre-
dominantly found on the surface of the bundle, facing
the lipid, whereas several conserved residues are
oriented towards the center of the bundle, particularly
in the area surrounding heme b . Type C anchorsH
show less sequence conservation in the lower part
and contain more bulky amino acids facing the cen-
w xter, consistent with the absence of heme b 17 .L
The proposed structure is consistent with an impor-
tant role of heme in assembly and stability of the
membrane anchors. The position of helices III and VI
can not be predicted with certainty, but we have
chosen to position these helices in contact with the
N-terminal ends, where they can act as stabilizing,
‘hydrophobic zippers’. Two heme groups are always
present in the Type B anchors lacking one of these
helices. Type C and D anchors lacking one or both
hemes may for reasons of stability retain helix III.
Type A anchors, predicted to have the most stable
configuration, have so far only been found in archae-
bacteria living under extreme conditions.
The hydrophilic stretches between helix II and III,
and between helix V and VI show a high degree of
sequence conservation compared to the other loops.
The reason for this may be that they interact with the
w xhighly conserved FPrIP 17 . As mentioned, some
SQRrQFR can be split into a soluble FPrIP domain
and a membrane anchor domain. The soluble domain
can be rebound to the anchor domain, provided that
w xthe 3Fe-4S cluster is kept reduced and protected
from oxidants. The strength of FPrIP binding to the
w xmembrane anchor varies among different species 14 .
The polypeptide between helix II and III was labeled
in a quinone photolabel study using bovine heart
w x .SQR 123 Fig. 7B as will be further discussed in
Section 10. Interestingly, a ubiquinone analogue can
protect mitochondrial SQR against splitting into
w xFPrIP and anchor peptides 124,125 . Reconstitution
of FPrIP to mammalian membrane anchor poly-
peptides could also be inhibited by DCCD, indicating
that carboxyl groups are involved in the interaction
w x126 . Notably, aspartate and glutamate residues are
often conserved in the hydrophilic loops between
helices II and III and between helices V and VI Fig.
.7B,C .
9.5. The anchors without heme
The most well studied Type D membrane anchor is
that of E. coli QFR, and it is also found in QFRs of
related bacteria, i.e., H. influenzae and P. ˝ulgaris.
This type of membrane anchor, lacking heme, may
also be present in yeast SQR but as discussed previ-
ously it is also possible that S. cere˝isiae contains
one SQR and one QFR. In spite the lack of heme it
seems like the Type D anchors have a similar struc-
ture as the heme containing anchors. They bind FP
and IP subunits which are well conserved in all
SQRsrQFRs. Furthermore the fully conserved bH
histidine axial ligand in SdhC, is also conserved in
the type D anchors. The corresponding histidine in
SdhD seems to be replaced with a cysteine in Type D
anchors. However, very recently the sequence of a
sdh operon from Mycobacterium tuberculosum, a
wstrictly aerobic bacterium, became available Q10760,
xQ10761, Q10762, Q10763 . These SdhC and D are
remarkably similar to those of E. coli FrdC and D
but contains the histidine conserved in SdhD Fig.
.7B,C . It is not known whether this SQR contain
heme, but if it does, it must be regarded as a very
interesting ‘missing link’ between the heme-contain-
ing and the heme-less membrane anchors. FPrIP was
isolated from Mycobacterium phlei as a complex
w xwith a cytochrome b component 127 . A group of
functionally important amino acids pinpointed in a E.
coli QFR mutagenesis study are located almost ex-
clusively in the center of the four helix bundle, or in
the peptide stretch between helix IV and V. These
mutations are indicated in Fig. 7B,C and will be
discussed in Section 10.
In E. coli FrdC the conserved histidine corre-
sponding to the b axial ligand, H82, was subjectedH
to extensive site-directed mutagenesis and changed to
w x w xR 128,129 , Q, E, L and Y 130 . The mutants
assemble QFR but exhibit a latent instability ob-
served as a detergent-induced dissociation of FPrIP
from the anchor subunits. All mutants show some
decrease in SQR and QFR activity but exhibit near
wild type activities with the artificial electron accep-
torrdonors PMS and benzylviologen. The H82“R
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and H82“Y mutations had the most drastic effect.
The results can be interpreted such that H82 is part of
a quinone binding site. However, in the light of the
predicted common structure of all membrane anchors
one may speculate whether the Type D anchors con-
tain, for example a metal atom at this site. This
would stabilize the structure and contribute to the
architecture of a quinone binding site, just like heme
apparently does in the other anchors.
A fifth type of ‘membrane anchor’, which is not
similar to those in the previously known SQRrQFR
may recently have been discovered. SQR purified
from the obligate aerobic archaebacterium S. acido-
caldarius was shown to lack heme, and contain FP
 .  .66 kDa , IP 31 kDa and two smaller polypeptides
 . w x28 kDa and 12.8 kDa 131 . This SQR was pre-
dicted to contain a Type D membrane anchor, al-
though a 28 kDa SdhC is atypically large for a two
polypeptide anchor. SQR in S. acidocaldarius is
operating with caldariellaquinone which has a redox
midpoint potential similar to that of ubiquinone
 w x.q100 mV at pH 6.5 132 , i.e., this SQR is of Class
1. SQR was also isolated from Sulfolobus sp. Strain
7, a hyperthermophilic and acidophilic archaebac-
terium sometimes presumed to be S. acidocaldarius.
This enzyme was comprised of 66, 37, 33 and 12
w xkDa subunits and lacked heme 133 . However, the S.
acidocaldarius sdhABCD operon has recently been
cloned, and the sequence determination is completed
w xY09041 . SdhA and SdhB are similar to known
FPrIP but the SdhC and D subunits are different, and
exhibit very little hydrophobicity. The SQR is said to
be loosely membrane bound. SdhC in addition con-
tains an unusual accumulation of cysteines which are
conserved in a subunit from heterodisulfide reductase
from a methanogen. The SdhD may possibly contain
some hydrophobic stretch. S. Jansen, G. Schafer and¨
.R. Moll, personal communication .
No genes for SQRrQFR membrane anchor sub-
units have been detected in M. jannashi, although the
w xentire genome has been analysed 134 . In addition,
the postulated IP subunit in M. jannashi contains a
long C-terminal extension, also homologous to a
 .subunit of heterodisulfide reductase HdrB in M.
thermoautotrophicum. Taken together, these data in-
dicate that the M. jannashi polypeptide is IP, fused
to the S. acidocaldarium ‘SdhC’ equivalent polypep-
 .tide Fig. 6 . Thus, some archaebacteria contain a
novel type of subunit composition for SQRrQFR in
which FP and IP are conserved but the two additional
polypeptides are unrelated to SdhCrFrdC and
SdhDrFrdD. The ‘SdhC’ polypeptide is cysteine rich,
but without transmembrane segments, and homolo-
gous to HdrB. Unfortunately, the function of HdrB in
w xheterodisulfide reductase is not understood 83 . The
fourth polypeptide, ‘SdhD’ may provide some kind
of looser membrane anchoring.
9.6. Properties and functional role of heme
The role of heme in succinate:quinone oxidoreduc-
tases remains somewhat enigmatic.
It seems clear that heme has a role in assembly and
structure of the membrane anchor, as demonstrated
for B. subtilis and E. coli SQR. Heme b in mostH
enzymes has a sufficiently high E to be fully succi-m
 .nate reducible Table 1 , but there are examples of
heme b with extremely low midpoint redox poten-H
w xtial, for example that in B. taurus 135 . Even so, B.
taurus SQR preparations with a low heme content
also show low enzyme activity, and semiquinone
w xspecies are not detectable 136 . Furthermore, there
may be examples of heme-less anchors among SQRs
 .i.e., that of yeast as well as QFRs, although the
previously mentioned S. acidocaldarius SQR seems
to contain SdhC and D polypeptides unrelated to
other anchors, and thus may operate by a different
principle. It can be concluded that presence of heme
is not obligatory for succinate oxidation per se.
Two transmembraneously arranged hemes in the
membrane anchor is typical for Class 3 SQRs Table
.  .1 , one with higher heme b and one with lowerH
 .redox midpoint potential heme b . One exceptionL
seems to be SQR from the facultative alkaliphilic
Bacillus sp. strain YN-2000, which is reported to
contain one heme with E y64 mV, and usesm
w xmenaquinone as electron acceptor 137 . Intriguingly,
this cytochrome was fully succinate reducible in spite
of its rather low E . Another alkaliphile, Bacillusm
firmus OF4 seems to contain an SQR very similar to
that of B. subtilis, exhibiting 50% reduction of the
cytochrome b with succinate compared with dithion-
w xite 138 . When two hemes are present they can be
discriminated based on their different optical and
w xEPR properties 39,139 , in addition to their different
 .E values Table 1 . In B. subtilis the midpointm
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potential of the two hemes are affected by the envi-
ronment, i.e., they are q65 mV and y95 mV in
purified SQR and q16 mV and y132 mV in the
w xmembrane bound enzyme 39 . The lower potentials
are restored when the purified SQR is reconstituted
into liposomes. Hagerhall and Konstantinov, unpub-¨ ¨
.lished results . At alkaline pH also heme b can beL
 .reduced by succinate f70% reduction at pH 9.5 .
The redox midpoint potential of heme b is pHH
independent in the interval pH6 to pH8. Above pH8 a
slight decrease in E is seen. The midpoint potentialm
of heme b seemingly shows a linear pH dependenceL
of y30 mVrpH unit in the interval pH 6 to 9.5
 .Smirnova, Hagerhall and Hederstedt, unpublished .¨ ¨
w xThis corroborates a report by Cammack et al. 140
demonstrating only a weak pH dependence of mito-
chondrial heme b between pH 5.9 and 7.4.H
The kinetics of heme reduction in isolated W.
succinogenes QFR have been measured using the
w xfreeze-quench technique 79 . It was found that 40%
of heme b is reduced by succinate within 100 msH
 y1.ks23 s . Heme b was fully reduced by theH
water soluble, low potential quinone analogue
 .  y1.DMNH Fig. 2 within 30 ms ks155 s and2
reoxidized by fumarate at essentially the same rate.
These rate constants show that electron transfer is at
least as fast as the enzyme turnover, i.e., heme could
be involved in electron transfer fromrto quinone.
10. Quinone interaction
As already discussed, different organisms use dif-
ferent quinones as electron acceptorsrdonors to
 .SQRrQFR Table 1 , Class 1 SQRs are using a
quinone with a higher redox midpoint potential such
as ubiquinone, whereas Class 2 QFRs and Class 3
SQRs are using a quinone with lower redox potential
such as menaquinone. The structures of common
quinones and quinone analogues are shown in Fig. 2.
To be able to explore quinone–enzyme interactions a
combination of inhibitors and mutants is useful, as
demonstrated by the progress made on the bc -com-1
 w x.plex Complex III, cf. 141,142 .
 .The quinone binding site s of SQRrQFR are
localized to the membrane part of succinate:quinone
oxidoreductase. The B. taurus SQR membrane an-
chor polypeptides were both photolabeled with
w3 x w xH aryloazidoquinone derivatives 143 . Later on one
peptide stretch, indicated in Fig. 7B, was singled out
as quinone binding in a labeling study using the same
w xenzyme 123 .
10.1. Quinone specificity and inhibitor sensiti˝ity
Purified B. subtilis SQR and W. succinogenes
QFR were assayed in parallel and showed SQR and
QFR activities with both naphto- and benzoquinones
w x57 . The enzymes exhibited little quinone specificity.
Rather the redox potential of the quinonerquinol
used determined the turnover rate. This phenomenon
was seen both with water soluble and non-water-solu-
ble quinones. Similar conclusions can be drawn from
w xexperiments with other SQRsrQFRs 138,144,145 .
There are several inhibitors that interfere with
quinone binding in SQRrQFR. The most well known
 .are 2-thenoyltrifluoroacetone TTFA , 3-methyl-
carboxin and 2-n-heptyl-4-hydroxyquinoline-N-oxide
 .  .HQNO , Fig. 2 . Sensitivity to these inhibitors vary
greatly and seemingly somewhat randomly among
 .species and enzyme types Table 1 . This is in agree-
ment with the poor sequence similarities in the areas
of IP and the membrane anchor that have been
indicated to be involved in quinone binding Fig.
.7B,C . Assuming that extensive variability can be
tolerated at the quinone binding sites, but that the
location of these sites on the protein is conserved, we
can draw some conclusions about quinone binding
sites by combining evidence obtained from various
SQRsrQFRs.
10.2. The EPR detectable semiquinone radical pair
( )Qs
Since quinones are two electron carriers the
SQRrQFR protein must be able to stabilize
semiquinone species. The existence of a stable
semiquinone pair in B. taurus SQR, denoted SQ ,s
has been demonstrated with EPR spectroscopy based
on a rapidly relaxing gs2.00 semiquinone signal as
well as low temperature detectable complex split
signals arising from spin–spin interactions between
w xtwo semiquinones 136,146,147 . From modeling of
the dipolar coupling using a point charge approxima-
tion, the distance between the two semiquinones was
˚ w xestimated to be 7.7 A 146 . Potentiometric analysis
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of the signal showed two E ’s of q140 and q80m
 .mV at pH 7.4 for the ubiquinone to ubisemiquinone
and ubisemiquinone to ubiquinol state, respectively,
w xin submitochondrial particles 106 . These values cor-
respond to a stability constant of approximately 10,
and was an early strong indication for the existence
of binding sites for the quinone species. The stability
constant of free ubisemiquinone in a hydrophobic
y10 w xmilieu has been estimated to be 10 148 . The two
E s are q40 mV and q128 mV respectively, inm
w xisolated beef heart SQR 147 corresponding to a
stability constant of 10y1, whereas in Complex II
plus III preparations the stability constant is interme-
diate to those observed in the two former cases. The
SQ signal is not detected in enzyme preparationss
with a low heme content and not in isolated SQR
unless quinone has been added to the preparation.
Maximal radical concentration was observed when
quinone was added in a 5:1 molar ratio to flavin
w x147 . Oriented multilayers of bovine heart mitochon-
drial membranes were used to show that the
semiquinone pair most likely is ordered with the
quinone–quinone vector perpendicular to the mem-
w xbrane plane 149 . Significantly, the Q semiquinones
pair has only been observed in mammalian mitochon-
w xdria SQR, in some green plant mitochondria 150
w xand in mitochondria from Neurospora crassa 151 ,
but not in a wild type bacterial SQRrQFR. This has
been envisaged such that an interacting semiquinone
pair is being much more sensitive to perturbations
than a single semiquinone. A modest shift of ;40
mV in the midpoint potential of one quinone relative
to the other would cause almost complete lack of
EPR signal. Also a modest decrease in the binding
constants of the semiquinones would affect detection,
since the observed signal intensity depends on the
square of the semiquinone concentration.
10.3. A proximal quinone binding site
The mammalian SQR is sensitive to both TTFA
and carboxins, two inhibitors that share some com-
 .mon structural features Fig. 2 . Both inhibitors were
shown to interact with the same site, but carboxin
with one order of magnitude lower K than TTFAi
w x152 . These compounds inhibit PMS reductase activ-
ity to 50% and quinone reductase activity up to 95%
w x153 . These inhibitors block reoxidation of reduced
cluster S3 with quinone but do not prevent S3 from
w xbeing reduced by succinate 154 . Addition of TTFA
to heart submitochondrial particles resulted not only
in quenching of the hyperfine splitting originating
from the semiquinone pair in SQR, but also increased
the EPR signal amplitude of S3 and shifted its mid-
w xpoint redox potential 105,106 . Furthermore, a muta-
tion in U. maydis, conferring resistance to carboxin
was located within the S3 ligation motif Fig. 5B,
w x.107 . The PMS reductase activity of soluble FPrIP
preparations is not affected by these inhibitors, indi-
cating that the membrane anchor, directly or indi-
w xrectly, contributes to the inhibitor binding site 155 .
A later study confirmed these observations and
demonstrated carboxin binding to the membrane an-
chor subunits, but only in the presence of FPrIP.
Irradiation of azidocarboxanilide-inhibited SQR gen-
w xerated labeled membrane anchor polypeptides 156 .
The EPR and optical spectra of heme is sensitive to
inhibitors which block electron transfer from S3 to
w xquinone 135 . The presence of a ubiquinone ana-
logue protected mitochondrial SQR against splitting
w x w xinto FPrIP and anchor peptides 125 . See 14 for a
comparison of activities of soluble FPrIP and intact
SQR. All these data together indicate that one quinone
 .binding site is located close to the negative inside
of the membrane, bordering both IP and the mem-
brane anchor, in close contact with both iron-sulfur
cluster S3 and heme b .H
Notably, A. suum QFR shows low sensitivity to
TTFA which was discussed in the light of its reverse
w xfunction 48 . However, in B. taurus SQR the K fori
carboxin is very similar during succinate oxidation
w xand fumarate reduction 41 . E. coli SQR, that con-
tains the histidine implicated in carboxin interaction
w xin U. maydis is not sensitive to carboxins 14 ,
whereas the structurally and functionally similar P.
w xdenitrificans SQR is sensitive to this inhibitor 157 .
A carboxin resistant P. denitrificans mutant has a
mutation in SdhD in the loop connecting helix V and
 .VI D89“G, Fig. 7C further establishing the con-
tribution of the membrane anchor part to this binding
w xsite. 158 .
10.4. A distal quinone binding site
B. subtilis SQR and E. coli QFR are not sensitive
to TTFA and carboxins but are sensitive to HQNO
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 w x.Fig. 2 159,160 . In B. subtilis SQR HQNO blocks
quinone reductase and quinol oxidase activity but not
w xPMS reductase activity 39 . The W. succinogenes
QFR, structurally very similar to B. subtilis SQR, is
w xnot HQNO sensitive 57 . In B. subtilis we have not
detected a significant effect of HQNO on the EPR
properties or the thermodynamic behavior of S3.
Furthermore the previously mentioned B. subtilis
SQ“CG IP mutant enzyme shows the same appar-
w xent K for HQNO as the wild type enzyme 95 .i
Binding of HQNO to B. subtilis SQR causes a shift
in the cytochrome light absorption spectrum and in
 .the E of heme b about y60 mV , but has nom L
w xeffect on the E of heme b 160 . This indicatesm H
that the HQNO binding site in B. subtilis SQR is
located in the vicinity of heme b , i.e., close to theL
 .positive outside of the membrane. In the isolated B.
 .subtilis membrane anchor without FP and IP bound
the heme b can be reduced by succinate in theH
presence of catalytic amounts of purified SQR and a
 .low potential menaquinone analogue DMN, Fig. 2 .
Cytochrome in the previously mentioned B. subtilis
H28“Y membrane anchor mutant, that lacks heme
b but contains heme b , is not reducible under theL H
same condition, in spite of a favorable redox potential
of the remaining heme q30–q50 mV, Hagerhall¨ ¨
.and Hederstedt, unpublished data . Another B subtilis
mutant, H13“Y in SdhC is impaired in PMS and
quinone reductase activity as well as in quinol oxida-
tion. Residue H13 is located close to heme b in ourH
w xstructural model 116 and is conserved in all the
 w x.SQR membrane anchors Fig. 7B, 17 . The artificial
electron acceptor PMS seems to accept electrons
from the proximal, analogous to the TTFA and
.carboxin-binding site, and thus PMS activity is not
affected by HQNO in B. subtilis. These observations
suggest that in B. subtilis SQR two separate quinone
binding sites are present. One site is close to the
negative side of the membrane, near heme b andH
. w xS3 , the other site, where HQNO mainly acts 160 , is
close to the positive side of the membrane near
.heme b .L
It should be noted that HQNO is not a specific
SQRrQFR inhibitor. HQNO binds to the Q site ofi
the bc complex, i.e., the site where the stabilized1
semiquinone resides. Formate dehydrogenase and a
number of quinol oxidizing enzymes, including
QH -nitrate reductase, the o- and d-type ubiquinol2
w xoxidases 159 and DMSO reductase are HQNO sen-
sitive. As mentioned in Section 8, a recent paper
w xdescribes interaction of an engineered 3Fe-4S clus-
w xter in DMSO reductase with HQNO 109 , indicating
the presence of a proximal HQNO binding site. The
 .structure of HQNO resembles a semi naphtho quinone
 .Fig. 2 . The apparent K for HQNO of B. subtilisi
SQR increases with increasing pH, indicating that the
w xdeprotonated inhibitor is less efficient 161 . Taken
together, HQNO may preferentially bind to sites de-
signed to have a high affinity for semiquinone, and
thus even if HQNO binds to the distal quinone-bind-
ing site in B. subtilis SQR it may not necessarily
bind to a geographically similar site in other en-
zymes, but rather to a functionally similar site.
In this context it should be noted that although a
Q type semiquinone pair has not been detected ins
bacterial SQRrQFR we have detected an EPR signal
indicative of a stabilized semiquinone in E. coli
membranes containing the well characterized E29L
QFR mutant. The signal is sensitive to HQNO and
absent from membranes containing wild type QFR
and membranes from the parent strain, which is
deleted for QFR and SQR Hagerhall, Cecchini and¨ ¨
.  .Ohnishi, unpublished . Residue E29 Fig. 7B has
been proposed to facilitate protonationrdeprotonation
w xof quinone 130 in analogy with a glutamate residue
in the reaction center Q . Notably E29 is located atB
the position corresponding to residue H13 in B.
subtilis SQR. The previously mentioned B. subtilis
H13“Y mutant does however not exhibit a similar
EPR signal. Thus, it seems like HQNO binds to the
opposite site in E. coli QFR versus in B. subtilis
SQR, but to the analogous site in another quinol
oxidizing enzyme, DMSO reductase. At this point we
can however not exclude that inhibitor binding to one
site causes destabilization of a semiquinone at the
other site.
10.5. Where is Q located?s
A comprehensive mutagenesis search for quinone
binding sites was carried out in E. coli QFR. As a
w xresult Westenberg et al. 130 pinpointed a number of
amino acid residues in the E. coli QFR membrane
anchor, including the previously mentioned residue
E29, that are important for enzyme activity. These
residues are indicated in Fig. 7B,C, with ‘=’ for
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mutations affecting enzyme activity and ‘o’ for muta-
tions with little or no such effects. The essential
residues map to two different regions on the anchor
 .see also Fig. 7A , indicating the presence of two
transmembraneously arranged quinone-binding sites.
 .One site maps close to the negative inside of the
 .membrane and another site close to the positive
outside of the membrane, which assuming a con-
served topological distribution of the quinone binding
sites in SQRrQFR, correspond to the TTFArcarbo-
xin binding site in mammalian and P. denitrificans
SQR and the HQNO binding site in B. subtilis SQR
respectively.
As mentioned in Section 9, the mitochondrial
genome of some photosynthetic red algae, a zooflag-
ellate, and the liverwort M. polymorpha carry genes
w xsimilar to SQR anchor polypeptides 36,37,162 .
These mitochondrial sdhC genes are similar to the
nuclear and bacterial genes, but the corresponding
sdhD genes from the red algae and the liverwort but
.not from the zooflagellate deviate from other SdhD
polypeptides. The hydrophilic peptide stretch be-
tween helix IV and V, in E. coli QFR indicated to
contain the distal quinone binding site, is absent from
these postulated SdhDs. However, in plants it is not
unusual to observe an ongoing gene-migration from
mitochondria to the nucleus. Some genes present on
the mitochondrial chromosomes are also simultane-
ously present in the nucleus, one or the other being
w xthe functional gene 163 . It was thus not clear whether
these mitochondrial sdhC and sdhD encode func-
tional proteins or if they were pseudo-genes. Very
recent sequence information however reveals that the
same peptide stretch is also absent from the func-
 . w xtional A. suum SdhD cybS 164 and B. taurus
SdhD Shenoy and Yu, personal communication
w x.U 50987 . Thus one member of the EPR detectable
transmembrane semiquinone pair in B. taurus SQR
can not originate from this site. In retrospect, the
calculated distance between the two semiquinones is
a bit short, even if the estimation can be stretched
˚ ˚from 7.7A to up to 15 A, considering that S3 is
located close to the membrane surface, and heme bH
is accommodated between S3 and heme b .L
The Q semiquinone pair seems more likely tos
originate from a ‘double occupancy’ quinone site,
similar to that recently demonstrated for the Q siteo
w xin the bc -complex 165 . As discussed, the diheme1
Type A and B membrane anchors of SQRrQFR have
a different structure and heme organization than the
bc complex, even if both cytochromes contain trans-1
membraneously arranged heme b and heme b .H L
Indeed, in the bc complex the Q site is located1 o
 .toward the positive outside of the membrane, and
catalyzes exclusively oxidation of quinol. It is how-
ever similar in the sense that it resides between an
iron-sulfur cluster and a heme. The quinone pair at
 .the Q site denoted Q and Q are suggested too os ow
provide a conduit for the rapid movement of
semiquinone away from the oxidizing side in this
.case the Rieske cluster to reduce heme b . ThisL
process supposedly provides directionality, minimizes
the lifetime of the semiquinone and wasteful side
w xreactions 165 . In SQR we can imagine an opposite
purpose, i.e., movement of semiquinone away from
 .the reducing S3 side to prevent electron backflow.
In summary, accumulating evidence indicate that
there are two transmembraneously arranged quinone
binding sites in SQRrQFR. However, the distal site,
 .localized towards the positive outside of the mem-
brane, seems to be absent in several mitochondrial
SQRs, notably also in beef heart SQR where the Qs
semiquinone pair is readily observed. It can thus be
proposed that there is a proximal, Q -type quinoneo
binding site localized towards the negative, inside of
the membrane, in close contact with S3 and heme bH
 .Fig. 8 . Amino acid residues in the S3 ligation motif
in IP and residues between helix II and III in SdhC
Fig. 8. Drawing to illustrate the components of a proposed
ancestral succinate:quinone oxidoreductase enzyme. The indi-
cated redox components are found to various extents in present
day SQRsrQFRs.
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contribute to this quinone binding site, and possibly
also residues in the equivalent peptide stretch in
SdhD, between helix V and VI. Two extensively
conserved aspartate residues in these regions of SdhC
 .and SdhD Fig. 7B,C may be of particular interest.
This quinone binding site interacts with TTFA and
carboxin in mammalian mitochondria and P. denitrif-
icans, and accommodates two quinone molecules,
giving rise to the Q semiquinone pair observed ins
mammalian SQR. PMS is proposed to accept elec-
trons from this site or S3.
A second, distal quinone-binding site is localized
towards the positive, outside of the membrane, close
to heme b when present, and involve amino acidL
residues in the peptide stretch between helix IV and
V. The absence of this stretch, and thus this quinone
binding site in B. taurus SQR may in fact account
for the possibility of observing the Q radical pair ins
this SQR, and not in bacterial enzymes such as E.
coli QFR or B. subtilis SQR. It is at present rather
ambiguous to predict which other organisms do or do
not contain the distal site due to the low sequence
similarity in quinone binding regions. One can also
imagine such a site to be abolished by replacing
amino acids rather than deleting the whole stretch.
Future research will hopefully shed light on this
issue.
11. Evolution of SQRrQFR
The similar primary sequence of FP and IP and the
conserved structure of the membrane anchors of Type
A, B, C and D in archaebacteria, eubacteria and
eukaryotes demonstrate that succinate:quinone oxido-
reductase was present in the last universal ancestor.
w xThe ‘respiration early’ hypothesis 20,21 postulates
that the primordial enzyme does not have to be a
fumarate reductase. It is tempting to assume that the
reason for the current, seemingly unnecessary com-
plexity of SQRrQFR may be that the original en-
zyme had a more complex function. The peripheral
domain of the enzyme, FPrIP, comprising the dicar-
boxylate binding site and a set of redox groups
providing the ‘electric cord’ in the electron transfer
device has remained relatively constant over time.
The membrane anchor, which probably originally
was composed of two polypeptides and contained
 .two transmembraneously arranged hemes Type A ,
had key roles in the postulated, more complex func-
 .tion s of the enzyme. The Class 3 SQRs may in this
respect more closely resemble the ancestral enzyme,
whereas the enzymes of the two other classes repre-
sent degenerate, simplified forms. Among the respira-
tory chain complexes it seems like progenitors of bc1
complexes and terminal oxidases, but not of
 .NADH:quinone oxidoreductases Complex I , were
present in the last universal ancestor. Thus one can
postulate two scenarios, or possibly a combination of
the two.
 .1 The original SQR enzyme was designed to
carry out a thermodynamically unfavorable reaction,
i.e., oxidation of succinate and reduction of a low
potential quinone such as menaquinone or thermo-
plasmaquinone. Some organisms shifted to
ubiquinone or other higher potential quinones, or to
using the enzyme in the reverse direction. As a result
intrinsic functions were simplified or abolished, but
the original framework was maintained.
 .2 The original enzyme was an energy coupling
site, i.e., functioned as proton translocator. The en-
zyme may have retained this form in organisms
lacking coupling site 1, but has in those organisms
that acquired Complex I and thus sufficient proton
pumping capacity, or in those organisms utilizing it
as QFR, been allowed to degenerate to various de-
grees, loosing one or both of two transmembrane-
ously arranged hemes, andror loosing the distal
quinone binding site. These possibilities will be fur-
ther discussed in Section 12.
It is evident that larger enzyme assemblies can
evolve from a combination of preexisting functional
modules. For example, the nuoE, nuoF and nuoG
genes, encoding the NADH-dehydrogenase subcom-
plex of Complex I, are always clustered in bacteria.
In addition their deduced amino acid sequences show
significant similarity to that of NADq and NADPq
reducing hydrogenases. Chloroplast Complex I, that
prefers NADPH as a substrate, lacks the NuoG, E
and F subunit analogues, and uses instead a ferre-
doxin-NADPq reductase module as a primary elec-
tron input device. The other components of the
chloroplast enzyme complex are similar to mitochon-
drial and prokaryotic Complex I subunits. The NuoB,
NuoC, NuoD, NuoI, NuoH and NuoL subunits of
Complex I are homologous to E. coli formate hydro-
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gen lyase, a non-energy coupled enzyme, thus repre-
senting another functional module of Complex I. The
membrane-spanning NuoL, M and N subunits also
show large similarity to each other, apparently a
result from gene duplications of a primordial gene.
More surprising is that NuoL, M and N also show
remarkable sequence similarity to proposed NaqrHq
and KqrHq antiporters. The SQRrQFR of the ar-
chaebacteria S. acidocaldarium, and M. jannashi
have apparently not lost heme groups during the
course of evolution, but acquired or maintained an-
other type of anchorraccessory subunits combined
with FPrIP. If this combination was present in the
last universal ancestor it has seemingly been lost in
all branches except some of the archae. Heterodisul-
fide reductase is an integral membrane protein that in
some methanogens forms a functional complex with
cytochrome b and hydrogenase or F dehydroge-420
nase — an example of a proton pump working in a
w xhighly specialized environment 166 . Perhaps the
atypical SQR is an alternative partner in such a
supercomplex, providing reducing equivalents from
another source.
12. Electron transport in SQRrQFR
A dual pathway model for the electron flow in
cardiac SQR has previously been proposed, which
includes a two step reduction of quinone at different
w xsites 140,167 . In this model cluster S2 and the
 .single heme corresponding to heme b constitute aH
‘low potential’ pathway linking FADrFAD) and
QrQ) whereas clusters S1 and S3 comprise a ‘high
potential’ pathway linking FAD)rFADH and2
Q)rQH . In this model there is no place for the2
 .second heme corresponding to heme b . Also itL
does not explain how succinate oxidation with a low
potential final electron acceptor can occur. Theoreti-
cally there seems to be no requirement for the divi-
sion of the electron pathway into high and low
w xpotential arms 99 .
As mentioned in the section on FP, FAD is the
most likely first electron acceptor in SQRrQFR at
succinate oxidation. FAD is a two electron carrier, in
contrast to the other prosthetic groups in SQRrQFR
which are one electron carriers. The FAD free radical
state has a high stability constant, indicating that
FAD performs the ns2 to ns1 conversion re-
quired to transfer electrons from succinate to the
iron-sulfur clusters and vice versa within SQRrQFR.
The E of cluster S2rFR2 is generally very low,m
indicating that it has a structural function, or that it
merely facilitates electron transfer. The E of clusterm
S1rFR1 is high in Class 3 SQRs that operate with
low potential quinones, of intermediate redox poten-
tial in Class 1 SQRs using high potential quinones as
electron acceptors and low in Class 2 QFRs Table
.1 . This correlation offers a clue to an understanding
of the differences in these enzymes. W. succinogenes
QFR and B. subtilis SQR have the same type of
diheme membrane anchor, and both operate with
menaquinone. Yet they catalyze the reverse enzy-
matic reactions in vivo, and are representative of a
Class 2 and Class 3 enzyme respectively. As is
apparent from the scheme in Fig. 3, the main differ-
ence between the three classes is the midpoint poten-
tial of S1rFR1, which is high in the Class 3 enzyme.
The high potential center S1 seems to provide an
essential, energetically favorable step, needed to pull
the electrons from FAD into the SQR when the final
electron acceptor has a low E . Cluster S3 generallym
has a lower potential in enzymes operating with low
potential quinones, regardless if they are SQRs or
 .QFRs Table 1 . The indications that S3rFR3 is
close to a quinone-binding site make it possible to
conclude that the electron transfer sequence within
SQRrQFR most likely proceeds as:
succinaterfumarate l FAD l S1rFR1 l
 . S2rFR2 l S3rFR3l quinonerquinol see also
.Fig. 3 .
The involvement of heme in electron transfer in
SQRrQFR is unclear, as discussed in Section 9. The
presence of two transmembraneously arranged hemes
however intuitively implies that they should have a
role in transmembrane electron transfer, and at least
primarily not be present merely to stabilize the an-
chor. Considering the topological arrangement of
heme b and heme b , located on top of each otherH L
but ligated to different transmembrane helices Fig.
.7A , one may speculate that this organization has a
functional importance. The heme–heme negative co-
 .operativity for hemes in the oxidized state in mar-
w xquettes was reported to be 6.82–7.87 kJrmol 168 .
The heme groups may thus electrostatically attract
each other when one heme is reduced and the other is
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oxidized. The heme–heme attraction could possibly
be accompanied by a relative movement of the trans-
membrane helices in the four helix bundle see Fig.
.  .7A . The helix pairs I: IV and II: V in the four helix
bundle would move along with the hemes they are
ligating. Such movement would provide an explana-
tion to why succinate reduced B. subtilis SQR is
more unstable than oxidized or fully reduced enzyme.
It seems like a majority of the Class 1 SQRs retain
only one heme, heme b . If the topological arrange-H
ment of hemes discussed above has a functional
implication this feature is concomitantly lost. Further-
more, at least in some cases the distal quinone bind-
ing site seems to be absent, and the thermodynamic
behavior of quinones at the proximal site signifi-
cantly altered. It seems plausible that Class 1 SQR
can catalyze succinate oxidation and ubiquinone re-
duction using the previously drawn electron transfer
 .scheme, without any additional accessories Fig. 3 .
The single heme can be required to maintain the
architecture of the intricate proximal quinone binding
site, which in spite of altered thermodynamic proper-
ties of the quinone pair may still aid in preventing
electron back flow, or due to these altered properties
actually regulate such flow.
 . ( ) (The QFRs Class 2 contain zero E. coli , one A.
) ( ) (suum or two W. succinogenes hemes, and one A.
) ( )suum or two E. coli quinone binding sites. This
suggest that QFRs were invented more than once
during the course of evolution, and that they may not
all necessarily work with identical mechanisms. W.
succinogenes QFR contains a Type B anchor, and
may thus be trapped with hemes for stability purpose,
as previously discussed. The parasite mitochondrial
QFRs most likely evolved from a mitochondrial type
SQR, thus lacking the distal quinone binding site.
Sequence comparisons of FP also favor such a devel-
w xopment 64 . The E. coli type heme-less QFR evolved
independently. Also menaquinol or rhodoquinol oxi-
dation and fumarate reduction is plausible using only
the electron transfer scheme above. However, some
QFRs maintain two quinone binding sites. Perhaps by
rather oxidizing quinol at the distal quinone binding
site, protons can be deposited in a favorable location,
 .whereas the quinone s at the proximal site can func-
tion merely to facilitate electron transfer from the
distal site to FR3.
At our present stage of knowledge the Class 3
SQRs seem in most cases to have a ‘full set’ of
components, i.e., two transmembraneously arranged
hemes and the proximal and the distal quinone bind-
ing site as illustrated in Fig. 8.
A previously proposed functional model for the
two quinone binding sites was based on the photosyn-
thetic reaction center. The two quinone binding sites
pinpointed by the E. coli QFR mutagenesis study
were envisaged such that the proximal quinone bind-
ing site corresponded to Q , which is the primaryA
acceptor of electrons from the iron-sulfur cluster and
passes electrons one by one to the secondary quinone
at the distal quinone binding site, corresponding to
Q . Only this latter quinone exchanges with theB
w xquinone pool 130 . The reaction centers do however
not contain transmembraneously arranged quinone
binding sites. A quinone permanently occupies QA
and mediates the two electron transfer, via an iron
atom, to another quinone that is reduced, and ex-
changed at Q . This arrangement is suggested toB
protect the reaction center from backward electron
flow, that would result if electrons reach an empty
w xquinone binding site 169 . In this respect, a catabolic
enzyme have more possibilities to control electron
influx than a photosynthetic enzyme.
Quinonerquinol in the electron transfer scheme
correspond to the proximal, Q -type quinone bindingo
site, which presumably is present in all SQRsrQFRs.
If we imagine that in analogy with in the bc -com-1
plex, the distal quinone binding site is of Q -type, i.e.,i
can stabilize a semiquinone, we seemingly have an
inverted bc complex with respect to quinone-bind-1
ing sites, but not with respect to the orientation of
heme b and heme b . The postulated Q -type site inH L i
fact agrees with the observations that the Q site ofi
the bc complex interacts with HQNO, just as the1
distal quinone binding site in a Class 3 SQR i.e., that
.of B. subtilis . We can then proceed and envisage an
inverted ‘Q cycle’ with a proximal Q type site foro
the reduction of two quinones and a distal Q typei
site for the oxidation of one quinol during one cat-
alytic turnover. This concept is not new, and was
recently proposed by Dutton and colleagues,
 .manuscript in preparation as bases for a model
aiming to explain the high protonrelectron stoi-
chiometry of Complex I. In case of SQR we do not
have to be concerned about increasing the
protonrelectron stoichiometry, in fact it would be an
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unexpected surprise to translocate one proton per
electron using this enzyme.
In the bc complex the first step of catalytic1
oxidation of quinol at the Q site results in a highlyo
reactive, thermodynamically unstable ubisemi-
quinone, that provides the driving force for electro-
genic electron transfer across the membrane. This
semiquinone becomes oxidized by another quinone
molecule, bound at the Q site located towards thei
positive side of the membrane barrier, via two trans-
 .membraneously arranged hemes b b and b .L H
Quinone at the Q site serves as a collector of twoi
single electrons from heme b before returning aH
quinol to the membrane pool. The quinone pair at the
 .Q site denoted Q and Q are, as mentioned,o os ow
suggested to facilitate rapid movement of semiquinone
 .away from the oxidizing side the Rieske cluster to
reduce heme b . This process provides directionality,L
minimize the lifetime of the semiquinone and waste-
w xful side reactions 165 . In SQR we can imagine the
opposite purpose of the quinone pair, i.e., movement
 .of semiquinone away from the reducing S3 side to
prevent electron backflow. The oxidation of quinol at
the distal site would in turn be driven by the highly
reactive, thermodynamically unstable semiquinone
created at the proximal site, and the electron transfer
facilitated by the transmembraneously arranged
hemes. We do not know if any of the present day
SQR functions as a coupling site, but it is quite
feasible that an ancestral enzyme could have had
such a function. It is possible that proton pumping
abilities of present day SQRs have simply been over-
looked in bacterial systems, due to difficulties of
making coupled membrane particles, and the convinc-
ing negative results with the mitochondrial enzymes.
As to present day Class 3 SQRs the proposed
‘inverted Q-cycle’ mechanism as such could facilitate
reduction of low potential quinones by succinate,
since a second reductant participates in the catalytic
turnover. However this mechanism does not quite
comply with experimental observations. First, there is
no apparent reason why this mechanism should not
be able to operate in vitro as well. Furthermore, the
enzyme activity would be expected to be lower in the
presence of Dm q, not higher. As mentioned inH
Section 6, the succinate to oxygen respiratory activity
of B. subtilis is 13 times lower in membranes com-
pared to in intact bacteria and 90% of the respiratory
activity of intact bacteria is lost upon addition of a
w xprotonophore 56 . These findings rather support an
arrangement of quinone binding sites as in the previ-
ously mentioned Q rQ type model in the sense thatA B
transmembrane electron transfer would be facilitated
by Dm q. With the ‘Q ’ site exchanged for a Q -typeH A o
site, electron backflow could be more efficiently
prevented. However, this scheme is less attractive
since SQR would parasite on the proton gradient built
up by other enzymes. During certain growth condi-
tions B. subtilis membrane contains large amounts of
SQR but no detectable bc complex or Complex I,1
that could contribute to the buildup of a proton
gradient. Overexpression of SQR does also not im-
pair growth.
One possibility would be to propose a dual func-
tion for Class 3 SQRs — a slow but energy coupled
reaction in the absence of Dm q and a fast reactionH
utilizing Dm q when present. The suggested struc-H
tural flexibility of the membrane anchor could have a
role in switching between these two functions, i.e.,
making both or only the distal quinone binding site
able to exchange with pool quinone. This hypothesis
is highly speculative but can and should be experi-
mentally tested. I hope that both this and other con-
jectures as well as facts presented in this review will
stimulate thinking and be incentives for the design of
novel experiments. It is clear that we are far from
having any clear documentation on the functional
mechanism of Class 3 SQRs and much future work is
needed to understand the functional mechanism of all
succinate:quinone oxidoreductases.
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